Pain-free publishing for your best science.

Randy Schekman 2013 Nobel Laureate, Editor-in-Chief
"It’s no longer necessary to endure endless cycles of revision and requests for new experiments. eLife editors, who are all working scientists, commit to providing clear and constructive feedback quickly."

Supported by:

Logos of the 3 eLife funders: Max Planck Institute, Howard Hughes Medical Institute and Wellcome Trust

Why publish with us?

  • Speed
    Get your results out fast

    Initial decisions are made in a few days, post-review decisions in about a month, and most articles go through only one round of revision. Every author also has the option to make their accepted manuscript openly available shortly after receiving a final decision.

  • Great backing
    We support early career scientists

    To support job, tenure and funding applications, the eLife Senior editor who handles your paper is willing to write a letter of recommendation that describes the significance of your article.

  • Review process
    Taking the pain out of peer review

    The scientist editors who run eLife will give you feedback that’s constructive and fair. If invited to revise your work, you’ll receive a single consolidated list of comments, so that you know exactly what you need to do to get your work published.

  • Research assessment
    eLife will not promote the Impact Factor

    We’ll promote your work, and provide quantitative and qualitative indicators about its reach and influence. eLife is working to expand and enrich the concept of research impact beyond the use of a single number and a journal name.

  • Reach
    Get great exposure

    eLife papers get great media coverage in venues like the New York Times and National Geographic. We make every paper more accessible to a broad set of readers – including students, colleagues in other fields, and the public – through Impact statements, plain language summaries (eLife Digests), and selected expert commentaries (eLife Insights). Plus, eLife articles are immediately and freely available to the world.

  • Community driven
    Scientists make the decisions

    eLife is a unique, non-profit, researcher-driven initiative. Editorial decisions are made exclusively by working scientists in your field.

  • Marianne Bronner Caltech
    "We had a great experience publishing in eLife and were particularly amazed at the great publicity the paper received. My post-docs are now convinced that this is a good place to publish so I'm confident that the next paper we consider sending to [a high profile journal] will go to eLife."
  • Bassem Hassan KU Leuven
    "The reviewer consultation process where the reviewers, the reviewing editor and the senior editor all work together is fantastic. What a unique and positive experience. eLife is a truly transformative journal."
  • Wolf B. Frommer Carnegie Institution for Science
    "I am very happy my paper was accepted by eLife, but I have to say that it was a wonderful experience all around. Constructive criticism, plus rapid decisions and no big fuss. Congratulations for setting this journal up ... you guys will take eLife to the top."

Aims & scope

eLife publishes outstanding research in the life sciences and biomedicine, from the most fundamental and theoretical work, through to translational, applied, and clinical research. Our 19 Senior editors and 170-member Board of Reviewing Editors are among the most respected and accomplished individuals in their fields – from human genetics and neuroscience to biophysics and epidemiology.

Leadership team

  • Randy Schekman

    Randy Schekman was awarded the 2013 Nobel Prize in Physiology or Medicine, with James Rothman and Thomas Sudhof. He is Professor of Molecular and Cell Biology at the University of California, Berkeley, and an Investigator at the Howard Hughes Medical Institute. His work concerns the mechanism of membrane assembly and vesicular traffic in eukaryotic cells. He and his laboratory discovered many of the genes and proteins required for secretion in yeast and they have applied this knowledge to understand human genetic diseases that affect core components of the secretory machinery. Among other awards, he shared the Gairdner International Award, the Louisa Gross Horwitz Prize and the Lasker Award with James Rothman. A member of the American Academy of Arts and Sciences, the American Philosophical Society and the National Academy of Sciences, he was elected President of the American Society for Cell Biology in 1999 and served as Editor-in-Chief of the Proceedings of the National Academy of Sciences from 2006 to late 2011.

    Competing interests statement

    Randy Schekman has received funding from the HHMI, the UC Berkeley Miller Foundation and from the Glenn Foundation. He is the Editor-in-Chief of the Annual Reviews of Cell and Developmental Biology, Head of Faculty for Cell Biology for F1000, the Scientific Director of the Jane Coffin Childs Fund (ends 2012), and Chair of the Scientific Advisory Board of the Tamasek Life Science laboratory, Singapore (ends 2012). He was the Editor-in-Chief of the Proceedings of the National Academy of Sciences (until 2011), and was an elected Council member of the American Academy of Arts and Sciences (until this year).

  • Fiona Watt

    Fiona Watt is internationally recognised for elucidating the mechanisms that control epidermal stem cell renewal, differentiation and tissue assembly, and discovering how those processes are deregulated in disease. She obtained her DPhil from Oxford University and was a postdoc at MIT. She established her first laboratory at the Kennedy Institute in London and then moved to the Cancer Research UK (CR-UK) London Research Institute (formerly known as the Imperial Cancer Research Fund), where she worked for 20 years. From 2007 to 2012 she was the inaugural Herchel Smith Professor of Molecular Genetics at the University of Cambridge, Deputy Director of the Wellcome Trust Centre for Stem Cell Research and Deputy Director of the CR-UK Cambridge Research Institute. She has recently been appointed director of the Centre for Stem Cells and Regenerative Medicine at King’s College London. Fiona Watt is a member of EMBO, a fellow of the Academy of Medical Sciences and the Royal Society and an Honorary Foreign Member of the American Academy of Arts and Sciences.

    Competing interests statement

    Fiona Watt receives funding from the Wellcome Trust, the Medical Research Council, Cancer Research UK and the European Commission. She serves on the Editorial Boards of Seminars in Cell and Developmental Biology, Current Stem Cell Research and Therapy, Expert Review of Dermatology, Cell Stem Cell, StemBook, the Journal of Molecular Cell Biology, and EMBO Molecular Medicine. She is a member of the ‘Faculty of 1000’ online review service (section head, stem cells and regeneration). She is a member of the International Society for Stem Cell Research Board of Directors, a member of the Scientific Advisory Boards of the Canadian Stem Cell Network, Harvard Stem Cell Institute, Wellcome Trust Centre for Gene Regulation and Expression, North East England Stem Cell Institute, Institute for Integrated Cell-Material Sciences (iCeMS) of Kyoto University, Fondazione Piemontese per la Ricerca sul Cancro, Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Ontario-wide Stem Cell initiative and Centre for Commercialization in Regenerative Medicine, and the Institute of Bioengineering, Ecole Polytechnique Fédérale de Lausanne (EPFL). She is a member of the Wellcome Trust Investigator Awards, expert review group, Cell and Developmental Biology, and a member of the Steering Committee for the UK Stem Cell Bank.

  • Detlef Weigel

    Detlef Weigel received his PhD in 1988 from the Max Planck Institute for Developmental Biology. After postdoctoral work at the California Institute of Technology, he joined the faculty of the Salk Institute in 1993. Since 2002, he has been director of the Department of Molecular Biology at the Max Planck Institute for Developmental Biology. His current research interests range from plant development and miRNAs to natural genetic variation and evolutionary genomics. Examples of work during the past decade include the discovery of the first plant miRNA mutant, initiating the 1001 Genomes project for Arabidopsis thaliana, and discovering autoimmunity in hybrids as a potential barrier of gene flow. Among the awards he has received are the Young Investigator Award of the National Science Foundation, the Gottfried Wilhelm Leibniz Award of the Deutsche Forschungsgemeinschaft, and the Otto Bayer Award. He is a member of the US National Academy of Sciences, the German National Academy of Sciences Leopoldina and the Royal Society.

    Competing interests statement

    Detlef Weigel has received funding from the Max Planck Society, the Deutsche Forschungsgemeinschaft, the Foundation of the State of Baden-Württemberg, the German Ministry for Education and Research, the European Commission, the Human Frontiers Science Program Organization, and the US National Institutes of Health. He serves on the Editorial Boards of Annual Review of Cell and Developmental Biology, Genome Biology, EMBO Journal and EMBO Reports, and Mechanisms of Development. He is Chair-elect of EMBO, and is serving or has recently served on the Advisory Boards of the Epigenomics of Plants International Consortium, Bayer Crop Science, The Arabidopsis Information Resource, GrassRoots Biotechnology, Flanders Institute of Biotechnology, Temasek Life Sciences Laboratory, Sainsbury Laboratory Cambridge University and Sainsbury Laboratory Norwich.

Senior editors
  • Stylianos Antonarakis

    Stylianos E Antonarakis is Professor and Chairman of Genetic Medicine at the University of Geneva Medical School, and director of the iGE3 institute of Genetics and Genomics of Geneva. He is a physician-scientist, human geneticist, who extensively studied the relationship between genomic variation and phenotypic variation. He was educated in the University of Athens (MD and DSc) and the Johns Hopkins University School of Medicine (Human Genetics). His academic contributions at the Johns Hopkins and the University of of Geneva spans more than 30 years, and include the understanding of the molecular bases of monogenic disorders and complex genetic disorders including the beta-thalassemias, hemophilias, and trisomy 21, and the functional variability of the human genome. He has published extensively (more than 620 papers), is co-editor of the current edition of the classic textbook Genetics in Medicine, and he is listed as one of the highly cited scientists by the ISI institute (h-index 94). He was the President of the European Society of Human Genetics, and was recently elected as the next President of HUGO. His current interests and research projects are the functional analysis of the genome, effect of human genetic variation to phenotypic variation, the molecular pathogenesis of trisomy 21 and polygenic phenotypes, the functional characterization of the conserved fraction of the genome, diagnostics and prevention of genetic disorders, and the societal implications of genetics and genome research.

    Competing interests statement

    Stylianos Antonarakis has received funding from the Swiss National Science Foundation (SNSF), the European Union, the European Research Council (ERC), the National Institutes of Health, and the Lejeune, Gebert, and Ludwig foundations. He is the President-Elect of HUGO (the Human Genome Organization; term begins in 2013), a member of the scientific council of the SNSF, and chair of the Genetics panel of the ERC. He is a member of the Scientific Advisory Boards of Imagine (Paris), Bioacademy Institute (Athens), and the Centre for Applied Genomics (Toronto), and he is on the editorial boards of Annual Reviews of Genetics and Genomics and Genome Research.

  • Ian Baldwin

    Ian Baldwin studied biology and chemistry at Dartmouth College in Hanover, New Hampshire and graduated 1981 with an AB. In 1989, he received a PhD in Chemical Ecology from Cornell University, in the Section of Neurobiology and Behavior. He was an Assistant (1989), Associate (1993) and Full Professor (1996) in the Department of Biology at SUNY Buffalo. In 1996 he became the Founding Director of the Max Planck Institute for Chemical Ecology, where he now heads of the Department of Molecular Ecology. In 1999 he was appointed Honorary Professor at Friedrich Schiller University in Jena, Germany. In 2002 he founded the International Max Planck Research School at the Max Planck Institute in Jena. Baldwin's scientific work is devoted to understanding the traits that allow plants to survive in the real world. To achieve this, he has developed a molecular toolbox for the native tobacco, Nicotiana attenuata (coyote tobacco) and a graduate program that trains “genome-enabled field biologists” to combine genomic and molecular genetic tools with field work to understand the genes that matter for plant-herbivore, -pollinator, -plant, -microbial interactions under real-world conditions. He has also been driver behind the open-access publication efforts of the Max Planck Society.

    Competing interests statement

    Ian Baldwin has received funding from the Max Planck Society, the Deutsche Forschungsgemeinschaft, the US National Science Foundation, the AW Mellon Foundation, the European Research Council, and the Human Frontiers Science Program Organization. He currently serves on the editorial board of The Journal of Integrated Plant Biology; and previously, Oecologia, Ecological Studies Series, Chemoecology, and The Plant Journal. He serves on the advisory boards of the Copenhagen Plant Science Centre, Lytle Preserve, Brigham Young University, and more MPG programs than can be listed; and previously, the Institute of the Chemistry and Dynamics of the Geosphere, Jülich, the Minerva Center for Arid Ecosystems Research, Hebrew University, the Wissenschaftskolleg, Berlin, the Swiss NSF Priority Program "Plant Survival in Natural and Agricultural Ecosystems”, and the DFG Priority Programs "Biological radiations" and "Trophic interactions and dynamics of communities".

  • Catherine Dulac

    Catherine Dulac is a Howard Hughes Medical Institute Investigator, Higgins Professor of Molecular and Cellular Biology, and Chair of the Department of Molecular and Cellular Biology in the Faculty of Arts & Sciences at Harvard University. Her work explores the molecular biology of pheromone detection and signaling in mammals, and the neural mechanisms underlying age-, species-, and sex-specific behaviors. She graduated from the Ecole Normale Supérieure, Paris; received her PhD from the University of Paris VI at the Institute of Molecular and Cellular Embryology (Nogent-sur-Marne); and was a postdoctoral fellow at Columbia University. She is a Fellow of the American Academy of Arts and Sciences; of the American Association for the Advancement of Science; and a member of the French Academy of Sciences, Institute of France. She is a recipient of the Liliane Bettencourt Prize, the Richard Lounsbery Award, the Perl/UNC Neuroscience Prize and the IPSEN Foundation Neuronal Plasticity prize.

    Competing interests statement

    Catherine Dulac receives funding from the Howard Hughes Medical Institute and the National Institutes of Health. She is a member of the editorial boards of Current Opinion in Neurobiology and The Journal of Comparative Neurology. She is a member of selection committees for the following awards and prizes: McKnight Foundation Technical Innovation Award, Radcliffe Institute for Advanced Study Fellowship Program, The Esther A. and Joseph Klingenstein Fund, the New York Stem Cell Foundation Innovator Awards in Neuroscience, the Smith Family Awards Program for Excellence in Biomedical Research and the Searle Scholars. She also serves on the Scientific Advisory Boards for the following organizations: Senomyx, Allen Institute, Friedrich Miescher Institute for Biomedical Research, and the Max Planck Institute for Medical Research. She is a member of the Visiting Committee for MIT’s Department of Brain and Cognitive Sciences, and she serves as a reviewer for the National Institutes of Health Somatosensory and Chemosensory Study Section.

  • Tony Hunter

    Tony Hunter is the Renato Dulbecco Chair in Cancer Research, Director of the Salk Institute Cancer Center and an American Cancer Society Professor in the Molecular and Cell Biology Laboratory at the Salk Institute for Biological Studies in La Jolla. In 1979, through his work on tumor viruses, he discovered a new class of protein kinase that phosphorylate tyrosine. He has spent most of the last 35 years studying protein kinases and phosphatases, and the role of protein phosphorylation in cell proliferation and the cell cycle, and how aberrant protein phosphorylation can cause cancer. His group also works on other types of posttranslational modifications (PTMs), including ubiquitylation and sumoylation, and crosstalk between PTMs. He has received many awards for his work on tyrosine phosphorylation, including a Gairdner International Award, the Louisa Gross Horwitz Prize and the Wolf Prize. He is a Fellow of the Royal Society of London, a Member of the US National Academy of Sciences, the Institute of Medicine, and the American Philosophical Society.

    Competing interests statement

    Tony Hunter receives funding from the National Cancer Institute of the National Institutes of Health, and serves as Director of the Salk Institute Cancer Center funded by an NCI Cancer Center Support Grant. He is a Scientific Advisory Board member of the Sanford-Burnham Medical Research Institute Cancer Center, the Beth Israel Deaconess Cancer Center, the Van Andel Research Institute, and the Shanghai Institute of Biochemistry and Cell Biology. He is on the editorial boards of Cell, Molecular Cell, the Proceedings of the National Academy of Sciences, EMBO Journal, EMBO Reports, and Science Signaling. He serves as a member of the Wellcome Trust Investigator Awards Selection Panel.

  • Prabhat Jha

    Prabhat Jha has been a key figure in epidemiology and economics of global health for the past decade. He is the University of Toronto Endowed Professor in Disease Control and Canada Research Chair at the Dalla Lana School of Public Health, and the founding Director of the Centre for Global Health Research at St. Michael's Hospital in Toronto. Professor Jha is a lead investigator of the Million Death Study in India, which quantifies the causes of premature mortality in over one million homes from 1997 &ndash 2014 and which examines the contribution of key risk factors such as tobacco, alcohol, diet, and environmental exposures. He is co-investigator of the Disease Control Priorities Network and the author of several influential books on tobacco control, including two that helped enable a global treaty on tobacco control, now signed by over 160 countries. Prior to founding CGHR, Professor Jha served as Senior Scientist for the World Health Organization, where he co-led the work on health and poverty for the Commission on Macroeconomics and Health. Earlier, he headed the World Bank team responsible for developing the Second National HIV/AIDS Control Program in India. His advisory work has included the Government of South Africa on its national health insurance plan, and the United States Institute of Medicine on global health. Notable recognitions include The Luther Terry Award for Research on Tobacco Control (2012), The Globe and Mail 25 Transformational Canadians (2010), Top 40 Canadians under Age 40 Award (2004), the Ontario Premier’s Research Excellence Award (2004), and Gold Medal from the Poland Health Promotion Foundation (2000). Professor Jha holds an MD from the University of Manitoba and a DPhil from Oxford University, where he studied as a Canadian Rhodes Scholar.

    Competing interests statement

    Prabhat Jha has received funding from the Bill and Melinda Gates Foundation, Canadian International Development Research Agency, Canadian International Development Agency, the International Science and Technology Program of the Canadian government, and the US National Institutes of Health. He serves on the editorial board of Demography India. He advises several agencies and the Canadian government on epidemiology, disease control strategies, and tobacco control, and serves on the advisory board of the UK Biobank.

  • John Kuriyan

    John Kuriyan is Professor of Molecular and Cell Biology and also of Chemistry at the University of California, Berkeley. Before this, he was on the faculty at The Rockefeller University, New York, where he began his career in 1987, leaving for Berkeley in 2001. Since 1990, he has been an Investigator of the Howard Hughes Medical Institute. Kuriyan completed undergraduate studies in chemistry at Juniata College, Huntingdon, PA. His doctoral research, on the dynamics of proteins, was carried out at MIT, under the guidance of Greg Petsko and Martin Karplus (Harvard University). Kuriyan’s research is aimed at understanding the structure and mechanism of the enzymes and molecular switches that carry out cellular signal transduction and DNA replication. His laboratory uses x-ray crystallography to determine the three-dimensional structures of proteins involved in signaling and replication, as well as biochemical, biophysical, and computational analyses to elucidate mechanisms. Kuriyan was elected to the U.S. National Academy of Sciences in 2001.

    Competing interests statement

    John Kuriyan has received funding from the Howard Hughes Medical Institute, the US National Institutes of Health, and the Leukemia and Lymphoma Society. He serves on the editorial board of the Proceedings of the National Academy of Sciences, and on the Scientific Advisory Boards of Carmot Therapeutics (San Francisco) and Jubilant Biosys (Bangalore). He is a founder of Nurix (San Francisco).

  • Richard Losick

    Richard Losick is the Maria Moors Cabot Professor of Biology, a Harvard College Professor, and a Howard Hughes Medical Institute Professor in the Faculty of Arts & Sciences at Harvard University. He received his A.B. in Chemistry at Princeton University and a Ph.D. from MIT. He was a Junior Fellow of the Harvard Society of Fellows. He is a past Chairman of the Departments of Cellular and Developmental Biology and Molecular and Cellular Biology. He is a member of the National Academy of Sciences, a Fellow of the American Academy of Arts and Sciences, a Member of the American Philosophical Society, a Fellow of the American Association for the Advancement of Science, and a Fellow of the American Academy of Microbiology. He is a recipient of the Camille and Henry Dreyfus Teacher-Scholar Award, the Selman A. Waksman Award of the NAS and the Canada Gairdner Award.

    Competing interests statement

    Richard Losick receives research funding from the National Institutes of Health and the BASF Corporation. He is a member of the scientific advisory board for the Jane Coffin Childs Fund and the Global Alliance for Tuberculosis. He is a member of the Board of Directors for the Foundation for Individual Rights in Education.

  • Vivek Malhotra

    Vivek Malhotra

    was a professor in the biology division at UC San Diego until 2007 and is now the ICREA Professor and Chair of the Cell and Developmental Biology at Center for Genomic Regulation (CRG) in Barcelona. His research focuses on a central station of the secretory pathway, the Golgi complex. Specifically, his work has resulted in the identification of the machinery required for the sorting and packaging of secretory cargoes. His recent work has uncovered a novel secretory routing that bypasses the conventional pathway of protein secretion. He received his BSc from Stirling University and was a Pirie–Reid scholar at Oxford; a Damon Runyon Walter Winchell and an American Cancer Society postdoctoral fellow at Stanford; and Basil O’Conner scholar, established Investigator of the American Heart Association, and Senior Investigator of Sandler’s Foundation for Asthma at UC San Diego. He received the MERCK award from the American Society of Biochemistry and Molecular Biology, is a fellow of the American association of the arts and science, and is an elected EMBO member.

    Competing interests statement

    Vivek Malhotra receives funding from ERC/European Research Council, Ministerio de Economía y Competitividad, AGAUR and the Plan Nacional (Spain) He is a Scientific Advisory Board member of TIGEM (Naples, Italy), CNR (Naples, Italy), CBMSO (Madrid, Spain) and Department of Biotechnology (India). He has served on the editorial board of Cell and was an associate editor of Molecular Biology of the Cell. He is currently on the editorial boards of Journal of Cell Biology and Current Opinion in Cell Biology.

  • James Manley

    James Manley received a BS from Columbia University, a PhD from Stony Brook/Cold Spring Harbor Labs, and did postdoctoral work at MIT. He has been in the Department of Biological Sciences at Columbia University since 1980, was Chair from 1995–2001, and Julian Clarence Levi Professor of Life Sciences since 1995. His research interests center on understanding the mechanisms and regulation of gene expression in eukaryotes, especially with regard to mRNA splicing and 3’ end formation; how these processes are linked to transcription, cell signaling pathways, and maintenance of genomic stability; and how they contribute to cell differentiation and disease. He has authored or coauthored nearly 300 research articles and reviews on these topics, and is an ISI Highly Cited Researcher. Dr. Manley is a Fellow of the American Academy of Microbiology, the American Academy of Arts and Sciences, and the American Association for the Advancement of Science, and a member of the National Academy of Sciences.

    Competing interests statement

    Jim Manley receives research support from the National Institutes of Health and Columbia’s Motor Neuron Center. He is currently an Associate Editor of Gene Expression and Editor of Molecular and Cellular Biology. He is also on the editorial boards of Genes and Development, RNA, Molecular Cell, BMC Molecular Biology, BMC Biology, Recent Patents on DNA & Gene Sequences, and Transcription.

  • Eve Marder

    Eve Marder is the Victor and Gwendolyn Beinfield Professor of Neuroscience at Brandeis University. Marder is a Past President of the Society for Neuroscience (SfN). Marder is a member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences, and a Fellow of the Biophysical Society, the American Association for the Advancement of Science, and the International Society of Neuroethology. She received the Miriam Salpeter Award from WIN, the WF Gerard Prize from the SfN, the Miller Prize from the Society for Cognitive Neuroscience, the Karl Spenser Lashley Prize from the American Philosophical Society, and the Gruber Prize in Neuroscience. Marder served on the NIH BRAIN Initiative working group. Marder studies the dynamics of small neuronal networks, and her work was instrumental in demonstrating that neuronal circuits are not "hard-wired" but are reconfigured by neuromodulators to produce a variety of outputs. She now studies the extent to which similar network performance can arise from different sets of network parameters.

    Competing interests statement

    Eve Marder is employed by Brandeis University. She receives research and training funding from the National Institutes of Health, the Leir Foundation, and the Swartz Foundation. She serves on the Scientific Advisory Board of Janelia Farm. She is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, a Fellow of the American Association of Science, and a Fellow of the Biophysical Society. She presently serves on editorial boards of Current Biology, Current Opinion in Neurobiology, and Progress in Neurobiology.

  • Michael Marletta

    Michael Marletta is the President and CEO of The Scripps Research Institute. He is also the Cecil H. and Ida M. Green Professor of Chemistry. Previous to his appointment at Scripps, he was on the faculty of the University of California, Berkeley, the University of Michigan, and MIT. He was a HHMI Investigator while at Michigan. Marletta obtained an A.B. in chemistry and biology from the State University of New York at Fredonia, a Ph.D. from UCSF under George Kenyon and after a postdoctoral appointment at MIT under Chris Walsh, began his independent career. His work has spanned protein chemistry and enzymology. He has made many contributions to our understanding of nitric oxide signaling and more generally in molecular mechanisms of gas sensing in eukaryotes and prokaryotes. More recent studies have involved novel enzymes involved with cellulose degradation. Marletta is a member of the National Academy of Sciences, the Institute of Medicine and American Academy of Arts and Sciences.

    Competing interests statement

    Michael Marletta has received funding from the NIH, HHMI, and Burroughs-Wellcome Fund. He is a member of the PNAS Editorial Board (until July 2012) and Biochemistry. He is a Scientific Advisory Board member of Lycera, Inc., Galleon Pharmaceuticals, Viamet Pharmaceuticals, and N30. He serves on the Scientific Review Board of HHMI. He is an External Review Board member of the Vanderbilt Institute of Chemical Biology, Georgia Tech School of Chemistry and Biochemistry, and Chair, Natural Science Advisory Council, SUNY Fredonia. He is a co-founder of Omniox, Inc.

  • Sean Morrison

    Sean Morrison

    The Morrison laboratory studies the cellular and molecular mechanisms that regulate stem cell function in the nervous and hematopoietic systems. Dr Morrison obtained his BSc in biology and chemistry from Dalhousie University (1991), then completed a PhD in immunology at Stanford University (1996), and a postdoctoral fellowship in neurobiology at Caltech (1999). From 1999 to 2011, Dr Morrison was at the University of Michigan where he Directed their Center for Stem Cell Biology. Recently, Dr Morrison moved to the University of Texas Southwestern Medical Center where he is the founding Director of the new Children’s Research Institute. Dr Morrison’s laboratory studies the mechanisms that regulate stem cell self-renewal and stem cell aging, as well as the role these mechanisms play in cancer. Dr Morrison was a Searle Scholar (2000–2003), was named in Technology Review Magazine’s list of 100 young innovators (2002), received the Presidential Early Career Award for Scientists and Engineers (2003), the International Society for Hematology and Stem Cell’s McCulloch and Till Award (2007), the American Association of Anatomists Harland Mossman Award (2008), and a MERIT Award from the National Institute on Aging. Dr Morrison has also been active in public policy issues surrounding stem cells. For example, he has twice testified before Congress and was a leader in the successful “Proposal 2” campaign to protect stem cell research in Michigan’s state constitution.

    Competing interests statement

    Sean Morrison receives funding from the Howard Hughes Medical Institute, the National Institutes of Health, and the Cancer Prevention and Research Institute of Texas. In addition to being a Senior editor for eLife, he is a member of the editorial boards of Cell Stem Cell, the Journal of Experimental Medicine, the EMBO Journal, the Faculty of 1000, Current Opinion in Cell Biology, Cancer Cell, EMBO Reports, and Stem Cell Reports. He serves on the scientific advisory boards of the California Institute for Regenerative Medicine, the University of Washington Institute for Stem Cells and Regenerative Medicine, the University of California, Los Angeles Broad Stem Cell Research Center, and the Common Fund for the National Institutes of Health Center for Regenerative Medicine. He is President-Elect of the International Society for Stem Cell Research. He is a co-founder and shareholder in OncoMed Pharmaceuticals, a consultant and shareholder in G1 Therapeutics, a shareholder in Fate Therapeutics, and a consultant for Molecular Devices.

  • Chris Ponting

    Chris PontingChris' research has had a substantial impact across diverse biomedical areas. The SMART domain database has been a major organisational principle that has proved to be of benefit across all of cellular and molecular biology; his evolutionary genomics research has provided guiding principles in differentiating genes that are similar – and those that are different – between model organisms and humans; his demonstration that at least 10% of the human genome is functional demarcates the experiments necessary to fully understand transcriptional regulation; and, his evolutionary studies on non-coding RNAs provided the justification required for many that these contribute greatly to biological complexity. Chris is Deputy Director of the Medical Research Council (MRC) Functional Genomics Unit, and is Professor of Genomics at the University of Oxford. He holds grants from the MRC, Parkinson's UK, and the European Research Council (Advanced Grant).

    Competing interests statement

    Chris Ponting receives funding from the UK Medical Research Council, the European Research Council, Wellcome Trust, Parkinson’s UK and Systems Biology Limited. He serves on the editorial boards of Genome Biology, Human Molecular Genetics, and the Annual Review of Genomics and Human Genetics. He is Deputy Director of the MRC Functional Genomics Unit, and an Associate Faculty Member of the Wellcome Trust Sanger Institute. He is an elected member of EMBO and the Academy of Medical Sciences. He serves on the Scientific Advisory Boards of ELIXIR and the Centre for Cancer Research and Cell Biology, Queen’s University.

  • K Vijay Raghavan

    K (Vijay) VijayRaghavan

    Vijay’s research aims to understand motor- and olfactory- circuit assembly: from deciphering how each component is made, interacts, and stabilises into functioning in the animal to allow behaviour in the real world. Related to the development of network function is its maintenance in the mature animal; another aspect of the work in the laboratory addresses how mature neurons and muscles are maintained. The laboratory uses a genetic approach, mainly using the fruit fly but also collaborating with those using mouse and cell-culture. VijayRaghavan is Professor and Director of the National Centre for Biological Sciences (NCBS) of the Tata Institute of Fundamental Research (TIFR) in Bangalore, India. He studied engineering at the Indian Institute of Technology, Kanpur. His doctoral work was at TIFR, Mumbai and postdoctoral work at the California Institute of Technology. NCBS is nurturing a new institute, inStem, and VijayRaghavan is its interim head.

    Competing interests statement

    K VijayRaghavan currently receives research support from the Indian Department of Biotechnology (DBT), the IndoFrench research agency CEFIPRA, and core support from the National Centre for Biological Sciences (NCBS), and Tata Institute of Fundamental Research (TIFR). Previous support was from the Rockefeller Foundation, the Wellcome Trust, the Indian Department of Science and Technology (DST), DBT, CEFIPRA, the Human Frontier Science Program (HFSP), and the US National Institutes of Health (NIH). In addition to his role as Director of the NCBSTIFR and acting Director of inStem, VijayRaghavan serves on the Board of Governors of the Okinawa Institute of Science and Technology, is a member of the Advisory Committee of the Janelia Farm Research Campus of the HHMI, a member of the Strategic Advisory Council to the Wellcome TrustDBT India Alliance, Chair of the Research Council of the Institute of Genomics and Integrative Biology, and Member of the Governing Council of the National Institute of Immunology. VijayRaghavan was Formerly Chief Editor, Journal of Genetics and is now a member of the editorial board. He is Associate Editor of BMC Developmental Biology, and a member of the editorial boards of Seminars in Developmental Biology and Bioconcepts. He was a member of the Scientific Advisory Board of Jubilant Life Sciences, Bangalore (until June 2012). He is Chair of the Board of the Center for Cellular and Molecular Platforms (C-CAMP), a not-for-profit company of the NCBS; and inStem, created to manage platform technologies and for technology transfer on the NCBSinStem campus. He is a member of the board of the Madhuram Narayanan Centre for Exceptional Children, a not-for-profit school for disabled children in Chennai, and a member of the Board of Trustees of the Human Frontier Science Program. VijayRaghavan is a member of the Science Advisory Council to the Prime Minister of India.

  • Aviv Regev

    Aviv Regev

    is a computational biologist who joined the Broad Institute as a core member and MIT as a faculty member in 2006. Her work investigates how complex molecular networks function and evolve in the face of genetic and environmental changes, over time-scales ranging from minutes to millions of years. Regev received her MSc from Tel Aviv University, studying biology, computer science, and mathematics in the Interdisciplinary Program for the Fostering of Excellence, where she undertook research in both theoretical and experimental biology. She received her PhD in computational biology from Tel Aviv University. Prior to joining the Broad Institute, Regev was a fellow at the Bauer Center for Genomics Research at Harvard University, where she developed new approaches to the reconstruction of regulatory networks and modules from genomic data. Regev is also an associate professor in the Department of Biology at MIT
and director of the Klarman Cell Observatory at the Broad. Regev is the Director of the Cell Circuits Program at the Broad and a lead principal investigator for the Center for Cell Circuits at the Broad Institute, a Center of Excellence in Genomic Science (CEGS). Regev has been a Howard Hughes Medical Institute (HHMI) Early Career Scientist since 2009, and was named a Howard Hughes Medical Institute (HHMI) Investigator in 2013. She is a recipient of the NIH Director’s Pioneer Award, a Sloan fellowship from the Sloan Foundation, the Overton Prize from the International Society for Computational Biology, and the Earl and Thressa Stadtman Scholar Award from the American Society for Biochemistry and Molecular Biology (ASBMB).

    (Image Credit: Maria Nemchuk)

    Competing interests statement

    Aviv Regev receives funding from the Howard Hughes Medical Institute, the National Institutes of Health, and the Sloan Foundation. She is on the external advisory board of the San Diego Center for Systems Biology, the FAS Center for Systems Biology at Harvard, the Simons Institute for the Theory of Computing, the Jackson Laboratory, the European Molecular Biology Lab (EMBL), the SciLife Lab in Sweden, and ThermoFisher Scientific. She is on the advisory editorial board of Molecular Systems Biology and is an editorial board member of Genome Biology and Development. Regev is a consultant for Syros Phramaceuticals, GenePeeks, and CTIG (Cancer Therapeutics Innovation Group). Regev also worked for several years in the biotech industry in Israel, where she established and directed a bioinformatics research and development team at QBI, a functional genomics company.

  • Janet Rossant

    Janet Rossant grew up in the UK and trained at the Universities of Oxford and Cambridge. She joined the Canadian Hospital for Sick Children in 2005 as Head of its Research Institute. She is also a university professor in the Department of Molecular Genetics at the University of Toronto. Throughout her career, she has been a pioneer in manipulating the mouse embryo, deriving novel stem cell lines and interrogating the mouse genome. She is a Fellow of the Royal Societies of London (2000) and Canada (1993), and a Foreign Associate of the National Academies of Science, USA (2008). She was awarded the McLaughlin Medal of the Royal Society of Canada (1998), Eli Lilly/Robert L. Noble Prize from the National Cancer Institute of Canada (2000), Killam Prize for Health Sciences (2004), and FASEB Excellence in Science Award (2004). She received the 2007 March of Dimes Prize in Developmental Biology along with the late Dr. Anne McLaren, and the 2007 Conklin Medal of the Society for Developmental Biology, of which she is a Past President.

    Competing interests statement

    Janet Rossant receives funding from the Canadian Institutes for Health Research, Ontario Research Fund, and the SickKids Foundation. She is on the editorial boards of Cell Stem Cell and Stem Cells, and she is a member of the Medical Advisory board of the Howard Hughes Medical Institute.

  • Charles Sawyers

    Charles Sawyers is an Investigator of the Howard Hughes Medical Institute and the Director of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center. His studies of BCR-ABL tyrosine kinase function in chronic myeloid leukemia, in collaboration with Brian Druker and Novartis, led to the development of the kinase inhibitor imatinib as primary therapy for CML. This was followed by his discovery that BCR-ABL kinase domain mutations confer imatinib resistance, and development of the second generation Abl kinase inhibitor dasatinib, in collaboration with Bristol Myers Squibb. Sawyers' current work in prostate cancer resulted in the novel antiandrogen MDV3100, discovered in collaboration with University of California-Los Angeles chemist Michael Jung, which is anticipated to be approved by the FDA in 2012. Sawyers is a member of the National Academy of Sciences and the Institute of Medicine and co-recipient of the 2009 Lasker~DeBakey Clinical Medical Research Award.

    Competing interests statement

    Charles Sawyers receives research funding from the Howard Hughes Medical Institute, the National Cancer Institute, the Starr Cancer Consortium, Stand Up to Cancer, and the Prostate Cancer Foundation. He is President Elect of the American Association of Cancer Research and will serve as President from 201314. He is a Councilor of the American Association of Physicians (until 2017) and serves on the editorial boards of Cell and Cancer Cell, and as a scientific advisor to Agios, Aragon, Aveo, Housey Pharmaceuticals, Merck, Nextech, Pfizer, and Tracon.

  • Tadatsugu Taniguchi

    Tada Taniguchi is currently Professor of the Department of Molecular Immunology, Institute of Industrial Science of The University of Tokyo and Director of the Max Planck–The University of Tokyo Center for Integrative Inflammology. He received his Ph.D. from the University of Zurich under the supervision of Charles Weissmann. His work principally concerns the mechanisms of signal transduction and gene expression that underlie immunity and oncogenesis. Many of his research projects have stemmed from his original identification of two cytokine genes, interferon-beta and interleukin-2. These discoveries have laid the groundwork for the molecular characterization of the various systems of cytokines as well as therapeutic advances achieved by the administration of cytokines. One extension of this research was his discovery of a new family of transcription factors, the interferon regulatory factors (IRFs), which he and others have since identified as playing integral roles in the regulation of the immune system and cancer. He has received numerous awards, including the Robert Koch Prize, Pezcoller-AACR International Award for Cancer Research, and was bestowed the Person of Cultural Merit award from the Government of Japan. He was also elected Foreign Associate Member of the National Academy of Sciences, USA, in 2003.

    Competing interests statement

    Tada Taniguchi has received funding from the Ministry of Education, Culture, Sports, Science & Technology in Japan. He is a member of the editorial boards of Annual Review of Immunology, Proceedings of the National Academy of Sciences, and Immunity. He is a member of the board of directors of the Japan Molecular Biology Society, and served as member of the Science Council of Japan between 2005 and 2011. He also served as co-chairperson of the International Affairs Committee of The American Association for Cancer Research between 2002 and 2008.

  • Diethard Tautz

    Diethard Tautz

    is Director of the Department for Evolutionary Genetics at the Max-Planck Institute for Evolutionary Biology in Plön, Germany. He did his PhD at the EMBL in Heidelberg, followed by postdoc phases on molecular evolution in Cambridge (UK) and on the molecular analysis of developmental processes in Drosophila at the MPI for Developmental Biology in Tübingen, where he joined the group of Herbert Jäckle. Together with Herbert Jäckle, he moved to the Department of Genetics of the University of Munich in 1988 and became Professor in the Department of Zoology in Munich 1991. In 1998 he moved to a chair in "Evolutionary Genetics" at the Department of Genetics of the University of Cologne and to his present position in 2006. In his research, he combined his interests in molecular evolution and developmental biology, and was one of the founders of the emerging Evo-Devo field. His current interests center around studying the genetics of adaptations, using wild populations of the house mouse as a model system. He is also continuing his work on molecular evolution, with a special emphasis on the de novo evolution of genes. He has served as Editor-in-Chief for Development, Genes and Evolution, and was a co-founder of the open-access journal Frontiers in Zoology.

    Competing interests statement

    Diethard Tautz is funded by the Max-Planck Society and the European Research Council. He currently serves as Senior Editor for Molecular Ecology and on the editorial board of Frontiers in Zoology, Development Genes and Evolution, Trends in Genetics, and Briefings in Functional Genomics and Proteomics. He serves on a number of Max-Planck committees as well as evaluation committees of the Leibniz Society and the Universities of Basel and Heidelberg.

  • Huda Zoghbi

    Huda Zoghbi is Professor of Pediatrics, Neurology, Molecular and Human Genetics, and Neuroscience at Baylor College of Medicine, Houston, Texas. She is also an Investigator with the Howard Hughes Medical Institute and Director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital. Her research focuses on understanding normal brain development and on elucidating the pathogenesis of several neurological disorders including the autism spectrum disorder, Rett syndrome, and late-onset neurodegenerative diseases.

    Competing interests statement

    Huda Zoghbi is actively receiving funds from the Howard Hughes Medical Institute, the National Institutes of Health, Rett Syndrome Research Trust, International Rett syndrome Foundation (and she is a member of advisory panels for all 4 organizations), Baylor College of Medicine, and Texas Children’s Hospital. She is Associate Editor of Annual Reviews of Neuroscience and a member of the editorial team of Cell and Neuron. She is Vice-Chair of the McKnight Neuroscience Fund and a member of the following Scientific Advisory Panels: the Jane Coffin Childs Fund, Diana Helis Henry Medical Research Foundation, Adrienne Helis Malvin Medical Research Foundation, Gruber Genetics Prize Jury, Janssen Prize Jury, Lasker Jury, and Vilcek Prize Jury. She was an elected member at large of the 2012 Class Membership Committee of the National Academy of Sciences.

Biochemistry

  • Douglas L Black
    University of California, Los Angeles (USA)
    Research focus
    • Pre-mRNA splicing
    • post-transcriptional gene regulation
    Experimental Organism
    • Human
    • Mouse
  • Michael R Botchan
    University of California, Berkeley (USA)
    Research focus
    • DNA replication
    • DNA repair
    Experimental Organism
    • Drosophila
    • Human
    • Mouse
  • Michael S Brown
    UT Southwestern Medical Center (USA)
    Research focus
    • Membrane proteins
    • sterol metabolism
    Experimental Organism
    • Human
  • Joanne Chory
    Salk Institute for Biological Studies (USA)
    Research focus
    • Hormone biosynthesis and metabolism
    • signal transduction
    • plant development
    Experimental Organism
    • Arabidopsis
  • Jon Clardy
    Harvard Medical School (USA)
    Research focus
    • Microbial secondary metabolism
    • chemical communications
    • biosynthesis
    • chemical biology
    • microbial chemical ecology
  • Philip Cole
    Johns Hopkins University (USA)
    Research focus
    • Chemical biology
    • signal transduction
    • epigenetics
  • Ben Cravatt
    Scripps Research Institute (USA)
    Research focus
    • Chemical biology
    • proteomics
    • neurochemistry
    • pharmacology
    Experimental Organism
    • Human
    • Mouse
  • Michael Czech
    University of Massachusetts Medical School (USA)
    Research focus
    • Insulin
    • metabolism
    • lipids
    • signal transduction
    • membranes
    • adipose
    • obesity
    • insulin resistance
    • diabetes
    Experimental Organism
    • Human
    • Mouse
  • Valerie Daggett
    University of Washington (USA)
    Research focus
    • Protein folding
    • protein dynamics
    • amyloid diseases
    • molecular dynamics
    • structural bioinformatics
  • Bart De Strooper
    VIB and KU Leuven (Belgium)
    Research focus
    • Protein processing
    • neurodegenerative diseases
    • animal models of human disease
    Experimental Organism
    • Human
    • Mouse
  • Raymond J Deshaies
    California Institute of Technology (USA)
    Research focus
    • Protein degradation
    • proteasome
    • proteolysis
    • ubiquitin
  • Ivan Dikic
    Goethe University (Germany)
    Research focus
    • Protein degradation
    • ubiquitin signalling
    • autophagy
    • NF-κB pathway
    • ubiquitin and DNA repair
    • receptor endocytosis
    • cell morphogenesis
    Experimental Organism
    • Mouse
  • Thomas Gingeras
    Cold Spring Harbor Laboratory (USA)
    Research focus
    • Noncoding RNA
    • genome organisation
    • transcriptome analyses
    • DNA sequencing methods
    • computational biology
    Experimental Organism
    • Drosophila
    • Human
    • Mouse
  • Ramanujan S Hegde
    Medical Research Council Laboratory of Molecular Biology (UK)
    Research focus
    • Protein translocation
    • endoplasmic reticulum
    • quality control
    • protein degradation
    • membrane protein insertion
    • protein aggregation
    • in vitro reconstitution
  • Helen Hobbs
    UT Southwestern Medical Center (USA)
    Research focus
    • Lipid metabolism
    • cholesterol
    • human genetics
    • atherosclerosis
    Experimental Organism
    • Human
  • Elisa Izaurralde
    Max Planck Institute Development Biology (Germany)
    Research focus
    • RNA degradation
    • RNA–protein biochemistry
    • microRNAs
    Experimental Organism
    • Drosophila
    • Human
  • Leemor Joshua-Tor
    Cold Spring Harbor Laboratory (USA)
    Research focus
    • RNA interference
    • DNA replication
    • gene expression
    • protein–RNA protein–DNA complexes
  • Werner Kühlbrandt
    Max Planck Institute for Biophysics (Germany)
    Research focus
    • Membrane proteins
    • membrane transport
  • James T Kadonaga
    University of California, San Diego (USA)
    Research focus
    • Transcription
    • chromatin dynamics
    • chromosomal proteins
    Experimental Organism
    • Drosophila
    • Human
  • Jeffery W Kelly
    Scripps Research Institute (USA)
    Research focus
    • Protein folding
    • protein aggregation
    • glycoproteins
  • Stephen C Kowalczykowski
    University of California, Davis (USA)
    Research focus
    • DNA–protein interactions
    • recombinational DNA repair
    • single-molecule biophysics
    Experimental Organism
    • E. coli
    • Human
    • S. cerevisiae
  • Wenhui Li
    National Institute of Biological Sciences, Beijing (China)
    Research focus
    • Viral entry
    • hepatitis B virus
    • hepatitis D virus
  • Noboru Mizushima
    University of Tokyo (Japan)
    Research focus
    • Protein degradation
    • lysosome
    • autophagy
  • Timothy Nilsen
    Case Western Reserve University (USA)
    Research focus
    • mRNA processing
    • mechanism of miRNA function
    • RNA–protein interactions
    • mRNP composition and function
    • RNA biology
    Experimental Organism
    • Drosophila
    • Human
    • Mouse
  • Jodi Nunnari
    University of California, Davis (USA)
    Research focus
    • Membrane structure and dynamics
    • mitochondria
    • organelle transport
    • apoptosis
  • Roy Parker
    University of Colorado at Boulder (USA)
    Research focus
    • Protein synthesis
    • mRNA stability
  • Jon Pines
    The Gurdon Institute (UK)
    Research focus
    • Cyclins and Anaphase Promoting Complex/Cycosome (APC/C)
    • cell cycle
    • mitosis
    • spindle assembly checkpoint
    Experimental Organism
    • Human
  • Nick J Proudfoot
    Oxford University (UK)
    Research focus
    • mRNA processing
    • transcription
    Experimental Organism
    • S. cerevisiae
    • S. pombe
    • Human
  • David Ron
    Cambridge University (UK)
    Research focus
    • Chaperones
    • unfolded protein response
    • oxidative protein folding
    • protein synthesis
  • Benoit Roux
    University of Chicago (USA)
    Research focus
    • Ion channels
    • cell signaling
    • molecular dynamics
    • theoretical and computational analysis of macromolecular systems
  • Feng Shao
    National Institute of Biological Sciences (China)
    Research focus
    • Bacterial infection
    • innate immunity
  • Ali Shilatifard
    Stowers Institute for Medical Research (USA)
    Research focus
    • Chromatin
    • ELLs
    • P-TEFb
    • Pol II
    • MLLs
    • chromosomal translocations and leukemia
    • enhancers
    • gene expression
    • transcription
    Experimental Organism
    • Drosophila
    • Human
    • Mouse
    • S. cerevisiae
  • Nahum Sonenberg
    McGill University (Canada)
    Research focus
    • Protein synthesis
    • cell signalling and translation
    • translational control of memory
    Experimental Organism
    • Mouse
  • Wilfred van der Donk
    University of Illinois at Urbana Champaign (USA)
    Research focus
    • Enzymology
    • chemical biology
    • natural product biosynthesis
    • cyclic peptides
    • antibiotics
  • Christopher T Walsh
    Harvard Medical School (USA)
    Research focus
    • Antibiotics
    • natural product biosynthesis
    • enzymes
    • antibiotic producing bacteria and fungi
  • Stephen G Young
    University of California, Los Angeles (USA)
    Research focus
    • Lipoproteins
    • nuclear lamins
    • atherosclerosis
    • triglyceride metabolism
    • cholesterol metabolism
  • Phil Zamore
    University of Massachusetts (USA)
    Research focus
    • RNA
    • RNA–protein biochemistry
    • enzymology
    • microRNAs
    Experimental Organism
    • Drosophila

Biophysics & structural biology

  • Richard Aldrich
    The University of Texas at Austin (USA)
    Research focus
    • Ion channels
    • conformational changes
    • calcium signaling
    • calmodulin
    • kinetics
  • Axel Brakhage
    Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Germany)
    Research focus
    • X-ray crystallography
    • single molecule microscopy
    • fungal pathogens
    • fungal secondary metabolism
    • biotechnology
    Experimental Organism
    • Aspergillus
  • Axel T Brunger
    Stanford University (USA)
    Research focus
    • Synaptic transmission
    • neurotransmitters
  • Arup K Chakraborty
    Massachusetts Institute of Technology (USA)
    Research focus
    • Computational biology
    • immunology
    • statistical mechanics
    • signaling
    • virology
  • Volker Dötsch
    Goethe University (Germany)
    Research focus
    • Membrane proteins
    • signal transduction
  • Valerie Daggett
    University of Washington (USA)
    Research focus
    • Protein folding
    • protein dynamics
    • amyloid diseases
    • molecular dynamics
    • structural bioinformatics
  • Stephen C Harrison
    Harvard Medical School (USA)
    Research focus
    • Structural biology
    • assembly and entry of viruses
    • membrane traffic
    • kinetochores
  • Gerhard Hummer
    The Max Planck Institute of Biophysics (Germany)
    Research focus
    • Theoretical biophysics
  • Reinhard Jahn
    Max Planck Institute for Biophysical Chemistry (Germany)
    Research focus
    • Membrane proteins
    • secretion
    • synaptic transmission
  • Leemor Joshua-Tor
    Cold Spring Harbor Laboratory (USA)
    Research focus
    • RNA interference
    • DNA replication
    • gene expression
    • protein–RNA protein–DNA complexes
  • Frank Jülicher
    Max Planck Institute for the Physics of Complex Systems (Germany)
    Research focus
    • Active cellular processes
    • physics of the cytoskeleton and motor proteins
    • physics of cell division
    • tissues and developmental processes
    • biophysics of hearing
  • Werner Kühlbrandt
    Max Planck Institute for Biophysics (Germany)
    Research focus
    • Membrane proteins
    • membrane transport
  • Jeffery W Kelly
    Scripps Research Institute (USA)
    Research focus
    • Protein folding
    • protein aggregation
    • glycoproteins
  • Stephen C Kowalczykowski
    University of California, Davis (USA)
    Research focus
    • DNA–protein interactions
    • recombinational DNA repair
    • single-molecule biophysics
    Experimental Organism
    • E. coli
    • Human
    • S. cerevisiae
  • Michael Levitt
    Stanford University (USA)
    Research focus
    • Protein folding
    • protein dynamics
    • structure prediction
    • structure determination and refinement by mass spectrometry
    • EM
    • X-ray
  • Ewa Paluch
    University College London (UK)
    Research focus
    • Actin cortex mechanics
  • Benoit Roux
    University of Chicago (USA)
    Research focus
    • Ion channels
    • cell signaling
    • molecular dynamics
    • theoretical and computational analysis of macromolecular systems
  • Sjors HW Scheres
    Medical Research Council Laboratory of Molecular Biology (UK)
    Research focus
    • Electron microscopy
    • molecular machines
  • Wesley Sundquist
    University of Utah (USA)
    Research focus
    • Virus-host interactions
    • retroviruses
    • HIV
    Experimental Organism
    • Human cells
  • Xiaowei Zhuang
    Harvard University (USA)
    Research focus
    • Single-molecule biology
    • protein–nucleic acid interactions
    • chromatin remodeling
    • super-resolution fluorescence microscopy

Cell biology

  • Edoardo M Airoldi
    Harvard University (USA)
    Research focus
    • Statistics
    • computational methods
    • proteomics
    • genomics
  • Mohan Balasubramanian
    Temasek Life Sciences Laboratory (Singapore) & University of Warwick (UK)
    Research focus
    • Cytokinesis
    • cell cycle
    • cytoskeleton
    Experimental Organism
    • S. pombe
  • Dominique Bergmann
    Stanford University (USA)
    Research focus
    • Cell polarity
    • plant development
    Experimental Organism
    • Arabidopsis
  • Andrea Brand
    The Gurdon Institute (UK)
    Research focus
    • Neural stem cells
    • neural development
    • developmental neurobiology
    Experimental Organism
    • Drosophila
  • Margaret Buckingham
    Institut Pasteur (France)
    Research focus
    • Cardiogenesis
    • muscle stem cells
    Experimental Organism
    • Mouse
  • Zhijian J Chen
    UT Southwestern Medical Center (USA)
    Research focus
    • Signal transduction
    • ubiquitin
  • Joanne Chory
    Salk Institute for Biological Studies (USA)
    Research focus
    • Hormone biosynthesis and metabolism
    • signal transduction
    • plant development
    Experimental Organism
    • Arabidopsis
  • Jonathan A Cooper
    Fred Hutchinson Cancer Research Center (USA)
    Research focus
    • Signal transduction
    • neuronal migration
    Experimental Organism
    • Mouse
  • Pascale Cossart
    Institut Pasteur (France)
    Research focus
    • Host-bacterial pathogens interactions (cell biology
    • transcriptional regulation
    • post-transcriptional regulation)
    Experimental Organism
    • Listeria
  • Michael Czech
    University of Massachusetts Medical School (USA)
    Research focus
    • Insulin
    • metabolism
    • lipids
    • signal transduction
    • membranes
    • adipose
    • obesity
    • insulin resistance
    • diabetes
    Experimental Organism
    • Human
    • Mouse
  • Volker Dötsch
    Goethe University (Germany)
    Research focus
    • Membrane proteins
    • signal transduction
  • Chi V Dang
    University of Pennsylvania (USA)
    Research focus
    • Cancer biology
  • Graeme Davis
    University of California, San Francisco (USA)
    Research focus
    • Neurodegeneration
    • neural development
    • synaptic transmission
    • plasticity
    Experimental Organism
    • Drosophila
  • Roger Davis
    University of Massachusetts Medical School (USA)
    Research focus
    • Signal transduction
    Experimental Organism
    • Mouse
  • Ivan Dikic
    Goethe University (Germany)
    Research focus
    • Protein degradation
    • ubiquitin signalling
    • autophagy
    • NF-κB pathway
    • ubiquitin and DNA repair
    • receptor endocytosis
    • cell morphogenesis
    Experimental Organism
    • Mouse
  • Joaquin Espinosa
    University of Colorado (USA)
    Research focus
    • Apoptosis
    • p53
    • tumor suppressors
    • cancer biology
  • James Ferrell
    Stanford University (USA)
    Research focus
    • Cell cycle
    • systems biology
  • Matthew Freeman
    Medical Research Council Laboratory of Molecular Biology (UK)
    Research focus
    • Cell signalling
    • trafficking
    Experimental Organism
    • Drosophila
    • Mouse
  • Christopher Glass
    University of California, San Diego (USA)
    Research focus
    • Nuclear receptors
    • transcription
    • transcriptional genomics
    • macrophage biology
    • inflammation
    Experimental Organism
    • Human
    • Mouse
  • Jean Greenberg
    University of Chicago (USA)
    Research focus
    • Local and long distance signalling in innate immunity
    • plant–microbe interactions
    • bacterial pathogens
    Experimental Organism
    • Arabidopsis
    • N. benthamiana
    • Tomato
    • Pseudomonas
  • Carol Greider
    Johns Hopkins University (USA)
    Research focus
    • Telomeres
    Experimental Organism
    • Mouse
    • S. cerevisiae
  • Christian S Hardtke
    University of Lausanne (Switzerland)
    Research focus
    • Computational model of development
    • plant development
    Experimental Organism
    • Arabidopsis
  • Ramanujan S Hegde
    Medical Research Council Laboratory of Molecular Biology (UK)
    Research focus
    • Protein translocation
    • endoplasmic reticulum
    • quality control
    • protein degradation
    • membrane protein insertion
    • protein aggregation
    • in vitro reconstitution
  • Oliver Hobert
    Columbia University (USA)
    Research focus
    • MicroRNAs
    • epigenetics
    • developmental neurobiology
    Experimental Organism
    • C. elegans
  • Tony Hyman
    Max Planck Institute of Molecular Cell Biology and Genetics (Germany)
    Research focus
    • Cell division
    • cytokinesis
    • cell polarity
    • organelles
    Experimental Organism
    • C. elegans
  • Elisa Izaurralde
    Max Planck Institute Development Biology (Germany)
    Research focus
    • RNA degradation
    • RNA–protein biochemistry
    • microRNAs
    Experimental Organism
    • Drosophila
    • Human
  • Reinhard Jahn
    Max Planck Institute for Biophysical Chemistry (Germany)
    Research focus
    • Membrane proteins
    • secretion
    • synaptic transmission
  • Werner Kühlbrandt
    Max Planck Institute for Biophysics (Germany)
    Research focus
    • Membrane proteins
    • membrane transport
  • James T Kadonaga
    University of California, San Diego (USA)
    Research focus
    • Transcription
    • chromatin dynamics
    • chromosomal proteins
    Experimental Organism
    • Drosophila
    • Human
  • Michael Laub
    Massachusetts Institute of Technology (USA)
    Research focus
    • Bacterial cell cycle
    • bacterial systems biology
    • signal transduction
  • Beth Levine
    UT Southwestern Medical Center (USA)
    Research focus
    • Autophagy
    • innate immunity
    Experimental Organism
    • C. elegans
    • Mouse
  • Joan Massagué
    Memorial Sloan Kettering Cancer Center (USA)
    Research focus
    • Cell signaling
    • cell fate
    • tumor biology
    • metastasis
    Experimental Organism
    • Human tissue
    • Mouse
  • Sheila McCormick
    University of California, Berkeley & USDA Agricultural Research Service (USA)
    Research focus
    • Cell polarity
    • signal transduction
    • plant gametophyte development
    • reproductive biology
    Experimental Organism
    • Arabidopsis
    • Tomato
  • Helen McNeill
    The Samuel Lunenfeld Research Institute (Canada)
    Research focus
    • Signal transduction
    • growth control
    • cell polarity
    • eye development
    Experimental Organism
    • Drosophila
  • Noboru Mizushima
    University of Tokyo (Japan)
    Research focus
    • Protein degradation
    • lysosome
    • autophagy
  • Thorsten Nürnberger
    University of Tübingen (Germany)
    Research focus
    • Innate immunity
    • plant–microbe interactions
    • plant immunity
    Experimental Organism
    • Arabidopsis
  • W James Nelson
    Stanford University (USA)
    Research focus
    • Cell polarity
    • cell adhesion
    • epithelia
    Experimental Organism
    • Dictyostelium
    • Human
    • Mouse
  • Jodi Nunnari
    University of California, Davis (USA)
    Research focus
    • Membrane structure and dynamics
    • mitochondria
    • organelle transport
    • apoptosis
  • Duojia Pan
    Johns Hopkins University (USA)
    Research focus
    • Signal transduction
    • growth control
    • cancer biology
    Experimental Organism
    • Drosophila
    • Mouse
  • Roy Parker
    University of Colorado at Boulder (USA)
    Research focus
    • Protein synthesis
    • mRNA stability
  • Suzanne R Pfeffer
    Stanford University (USA)
    Research focus
    • Membrane traffic
    • golgi complex
    • endosomes
    • lysosomes
    • secretory pathway
    • endosomes
    • lysosomes
  • Jon Pines
    The Gurdon Institute (UK)
    Research focus
    • Cyclins and Anaphase Promoting Complex/Cycosome (APC/C)
    • cell cycle
    • mitosis
    • spindle assembly checkpoint
    Experimental Organism
    • Human
  • Nick J Proudfoot
    Oxford University (UK)
    Research focus
    • mRNA processing
    • transcription
    Experimental Organism
    • S. cerevisiae
    • S. pombe
    • Human
  • Danny Reinberg
    New York University (USA)
    Research focus
    • Epigenetics
    • chromatin biology
  • David Ron
    Cambridge University (UK)
    Research focus
    • Chaperones
    • unfolded protein response
    • oxidative protein folding
    • protein synthesis
  • Alejandro Sánchez Alvarado
    Stowers Institute for Medical Research (USA)
    Research focus
    • Regeneration
    Experimental Organism
    • Planaria
  • Robert H Singer
    Albert Einstein College of Medicine (USA)
    Research focus
    • Transcription
    • mRNA localization
  • Nahum Sonenberg
    McGill University (Canada)
    Research focus
    • Protein synthesis
    • cell signalling and translation
    • translational control of memory
    Experimental Organism
    • Mouse
  • Kevin Struhl
    Harvard Medical School (USA)
    Research focus
    • Chromatin biology
    • cancer biology
    • transcription
    • gene regulatory circuits
    • epigenetics
    • molecular biology
    Experimental Organism
    • Human cells
    • S. cerevisiae
  • Peter Tontonoz
    University of California, Los Angeles (USA)
    Research focus
    • Nuclear receptors
    • lipid metabolism
    • obesity/diabetes
    • atherosclerosis
  • Johannes Walter
    Harvard Medical School (USA)
    Research focus
    • Cell cycle
    • DNA replication
    • DNA repair
    Experimental Organism
    • Xenopus
  • Karsten Weis
    ETH Zürich (Switzerland)
    Research focus
    • Nuclear transport
    • nuclear pore
    • mRNA transport
  • Richard J Youle
    National Institute of Neurological Disorders and Stroke (USA)
    Research focus
    • Mitochondria
    • cell death
  • Stephen G Young
    University of California, Los Angeles (USA)
    Research focus
    • Lipoproteins
    • nuclear lamins
    • atherosclerosis
    • triglyceride metabolism
    • cholesterol metabolism
  • Xiaowei Zhuang
    Harvard University (USA)
    Research focus
    • Single-molecule biology
    • protein–nucleic acid interactions
    • chromatin remodeling
    • super-resolution fluorescence microscopy

Developmental biology & stem cells

  • Julie Ahringer
    The Gurdon Institute (UK)
    Research focus
    • Cell fate
    • gene expression
    • chromatin biology
    • epigenetics
    Experimental Organism
    • C. elegans
  • Utpal Banerjee
    University of California, Los Angeles (USA)
    Research focus
    • Haematopoiesis
    • cancer biology
    Experimental Organism
    • Drosophila
  • Clare Blackburn
    MRC Centre for Regenerative Medicine, University of Edinburgh (UK)
    Research focus
    • Thymus development, maintainance, and regeneration
    • thymic epithelial progenitor cell biology and regulation
    • differentiation of pluripotent cells
    • transcription factor networks
  • Andrea Brand
    The Gurdon Institute (UK)
    Research focus
    • Neural stem cells
    • neural development
    • developmental neurobiology
    Experimental Organism
    • Drosophila
  • Marianne E Bronner
    California Institute of Technology (USA)
    Research focus
    • Neural crest
    • peripheral nervous system
    • placodes
    • developmental neurobiology
    Experimental Organism
    • Chick
    • Lamprey
    • Zebrafish
    • Xenopus
  • Margaret Buckingham
    Institut Pasteur (France)
    Research focus
    • Cardiogenesis
    • muscle stem cells
    Experimental Organism
    • Mouse
  • Philip Cole
    Johns Hopkins University (USA)
    Research focus
    • Chemical biology
    • signal transduction
    • epigenetics
  • Giulio Cossu
    University College London (UK)
    Research focus
    • Stem cells
    • cell therapy
    • muscular dystrophies
    • clinical trials of cell therapies
    Experimental Organism
    • Human
    • Mouse
  • Graeme Davis
    University of California, San Francisco (USA)
    Research focus
    • Neurodegeneration
    • neural development
    • synaptic transmission
    • plasticity
    Experimental Organism
    • Drosophila
  • Anne Ferguson-Smith
    Cambridge University (UK)
    Research focus
    • Imprinting
    • epigenetics
    • mouse development genetics
    • gene regulation
    • functional genomics
    Experimental Organism
    • Mouse
  • Elaine Fuchs
    Rockefeller University (USA)
    Research focus
    • Skin stem cells
    • stem cells
    • tissue morphogenesis
    • epithelial polarity
    • transcriptional regulation during development
    • cytoskeletal dynamics and adhesion
    • epithelial cancers
    Experimental Organism
    • Mouse
  • Christian S Hardtke
    University of Lausanne (Switzerland)
    Research focus
    • Computational model of development
    • plant development
    Experimental Organism
    • Arabidopsis
  • Oliver Hobert
    Columbia University (USA)
    Research focus
    • MicroRNAs
    • epigenetics
    • developmental neurobiology
    Experimental Organism
    • C. elegans
  • Robb Krumlauf
    Stowers Institute for Medical Research (USA)
    Research focus
    • Hox genes
    • vertebrate development
    • axial patterning
    • craniofacial development
    • gene regulatory networks
    • developmental neurobiology
    Experimental Organism
    • Mouse
  • Liqun Luo
    Stanford University (USA)
    Research focus
    • Developmental neurobiology
    • neural circuits
    • olfaction
    Experimental Organism
    • Drosophila
    • Mouse
  • Sheila McCormick
    University of California, Berkeley & USDA Agricultural Research Service (USA)
    Research focus
    • Cell polarity
    • signal transduction
    • plant gametophyte development
    • reproductive biology
    Experimental Organism
    • Arabidopsis
    • Tomato
  • Helen McNeill
    The Samuel Lunenfeld Research Institute (Canada)
    Research focus
    • Signal transduction
    • growth control
    • cell polarity
    • eye development
    Experimental Organism
    • Drosophila
  • Freda Miller
    The Hospital for Sick Children, University of Toronto (Canada)
    Research focus
    • Neural stem cells
    • neurodevelopmental disorders
    • neurotrophins
  • Jeremy Nathans
    Johns Hopkins University (USA)
    Research focus
    • Developmental neurobiology
    • planar cell polarity
    • photoreceptors
    • vision
    • ophthalmology
    Experimental Organism
    • Mouse
  • Hideyuki Okano
    Keio University (Japan)
    Research focus
    • Neural stem cells
    • inducted pluripotent stem cells
    • cell based therapies
    • spinal cord injury
    Experimental Organism
    • Mouse
    • Non-human primate (common marmoset)
  • Duojia Pan
    Johns Hopkins University (USA)
    Research focus
    • Signal transduction
    • growth control
    • cancer biology
    Experimental Organism
    • Drosophila
    • Mouse
  • Kathrin Plath
    University of California, Los Angeles (USA)
    Research focus
    • Reprogramming
    • X chromosome inactivation
    • embryonic stem cells
    • chromatin
    Experimental Organism
    • Mouse
  • Franck Polleux
    Columbia University (USA)
    Research focus
    • Cortical development
    • neuronal polarity
    • neuronal migration
    • axon and dendrite development
    • brain evolution
    Experimental Organism
    • Human
    • Mouse
  • Satyajit Rath
    National Institute of Immunology (India)
    Research focus
    • Immune physiology
    • lymphocyte development
    • lymphocyte responses
    • macrophage activation
    • immunity in disease
  • Alejandro Sánchez Alvarado
    Stowers Institute for Medical Research (USA)
    Research focus
    • Regeneration
    Experimental Organism
    • Planaria
  • Deepak Srivastava
    The Gladstone Institutes (USA)
    Research focus
    • Tissue stem cells
    • cardiac repair
    • cardiology
    Experimental Organism
    • Human
    • Mouse
  • Gordana Vunjak-Novakovic
    Columbia University (USA)
    Research focus
    • In vitro models of development and disease
    • biophysical regulation of stem cells
    • cardiac and bone regeneration
    • tissue engineering
    Experimental Organism
    • Human
  • Amy J Wagers
    Harvard University (USA)
    Research focus
    • Blood-forming stem cells
    • muscle-forming stem cells
  • Tanya T Whitfield
    University of Sheffield (UK)
    Research focus
    • Animal models of human genetic disease
    • deafness
    Experimental Organism
    • Zebrafish

Ecology

  • Carl T Bergstrom
    University of Washington (USA)
    Research focus
    • Game theory
    • network science
    • evolution
  • Jörg Bohlmann
    University of British Columbia (Canada)
    Research focus
    • Metabolism
    • chemical ecology
    • plant genomics
    Experimental Organism
    • Plants
  • Jon Clardy
    Harvard Medical School (USA)
    Research focus
    • Microbial secondary metabolism
    • chemical communications
    • biosynthesis
    • chemical biology
    • microbial chemical ecology
  • Marcel Dicke
    Wageningen University (The Netherlands)
    Research focus
    • Ecological entomology
    • plant–insect interactions
  • Maria J Harrison
    Boyce Thompson Institute for Plant Research (USA)
    Research focus
    • Plant–microbe symbioses
    • plant–microbe interactions
    • plant mineral nutrition
    Experimental Organism
    • Glomus
    • Medicago
  • Merijn R Kant
    University of Amsterdam (the Netherlands)
    Research focus
    • Chemical ecology
    • plant defense
    • plant–parasite interactions
    Experimental Organism
    • Tomato
    • insects
    • mites
  • Daniel J Kliebenstein
    University of California, Davis (USA)
    Research focus
    • Plant–microbe interactions
    • quantitative genetics
    • genome-wide association studies
    • plant genomics
    • ecological genomics
    • fungal genomics
    • secondary metabolism
    • plant–insect interactions
  • Mercedes Pascual
    University of Michigan (USA)
    Research focus
    • Population dynamics and pathogen diversity of infectious diseases
    • mathematical models in epidemiology
    • theoretical ecology
    • ecological networks
  • Wenying Shou
    Fred Hutchinson Cancer Research Center (USA)
    Research focus
    • Experimental evolution
    • evolution of cooperation
    • mathematical biology

Epidemiology & global health

  • Quarraisha Abdool Karim
    CAPRISA (South Africa)
    Research focus
    • Food-borne diseases
    • food policy
    • HIV/AIDS
    • immunisation
  • Eduardo Franco
    McGill University (Canada)
    Research focus
    • Human biology and medicine
    • microbiology and infectious disease
    • cancer epidemiology and prevention
    • screening
    • human papillomavirus infection
    Experimental Organism
    • Human
  • Simon I Hay
    Oxford University (UK)
    Research focus
    • Infectious diseases of the tropics
    • epidemiology
    Experimental Organism
    • Plasmodia
    • Leishmania
    • arboviruses
  • Mark Jit
    London School of Hygiene & Tropical Medicine, and Public Health England (UK)
    Research focus
    • Immunisation
    • health economics
    • mathematical modelling of infectious diseases
  • Catherine Kyobutungi
    Africa Population Health Research Center (Kenya)
    Research focus
    • Epidemiology of non-communicable diseases
  • Mercedes Pascual
    University of Michigan (USA)
    Research focus
    • Population dynamics and pathogen diversity of infectious diseases
    • mathematical models in epidemiology
    • theoretical ecology
    • ecological networks
  • Sema Sgaier
    Bill & Melinda Gates Foundation (USA)
    Research focus
    • Human biology and medicine
    • disease control
    • epidemiology
  • Stephen Tollman
    Wits University (South Africa)
    Research focus
    • Human biology and medicine
    • mortality
    • disease control in low income countries
  • Nicholas J White
    Mahidol University (Thailand)
    Research focus
    • malaria
    • drug discovery and therapeutics
    Experimental Organism
    • P. falciparum
    • P. vivax
    • B. pseudomallei

Genes & chromosomes

  • Karen Adelman
    National Institute of Environmental Health Sciences (USA)
    Research focus
    • Chromatin structure
    • gene expression
    • transcription
  • Julie Ahringer
    The Gurdon Institute (UK)
    Research focus
    • Cell fate
    • gene expression
    • chromatin biology
    • epigenetics
    Experimental Organism
    • C. elegans
  • Asifa Akhtar
    Max Planck Institute for Immunobiology and Epigenetics (Germany)
    Research focus
    • Gene expression
    • chromatin biology
    • epigenetics
    • transcription
    Experimental Organism
    • Drosophila
  • Richard Amasino
    University of Wisconsin (USA)
    Research focus
    • Epigenetics
    • plant development
    Experimental Organism
    • Arabidopsis
    • B. distachyon
  • David Baulcombe
    Cambridge University (UK)
    Research focus
    • Epigenetics
    • RNA silencing
    • plant defence mechanisms
    Experimental Organism
    • Arabidopsis
  • Douglas L Black
    University of California, Los Angeles (USA)
    Research focus
    • Pre-mRNA splicing
    • post-transcriptional gene regulation
    Experimental Organism
    • Human
    • Mouse
  • Benjamin J Blencowe
    University of Toronto (Canada)
    Research focus
    • RNA processing
    • epigenomics
    • transcriptome analyses
    Experimental Organism
    • Human
    • Mouse
  • Michael R Botchan
    University of California, Berkeley (USA)
    Research focus
    • DNA replication
    • DNA repair
    Experimental Organism
    • Drosophila
    • Human
    • Mouse
  • Roger Davis
    University of Massachusetts Medical School (USA)
    Research focus
    • Signal transduction
    Experimental Organism
    • Mouse
  • Bernard de Massy
    Institute of Human Genetics, CNRS (France)
    Research focus
    • Recombination
    • meiosis
    Experimental Organism
    • Mouse
    • S. cerevisiae
  • Joaquin Espinosa
    University of Colorado (USA)
    Research focus
    • Apoptosis
    • p53
    • tumor suppressors
    • cancer biology
  • Anne Ferguson-Smith
    Cambridge University (UK)
    Research focus
    • Imprinting
    • epigenetics
    • mouse development genetics
    • gene regulation
    • functional genomics
    Experimental Organism
    • Mouse
  • Nir Friedman
    The Hebrew University of Jerusalem (Israel)
    Research focus
    • Transcriptional regulation
    • comparative genomics
    • probabilistic models
    • computational biology
    Experimental Organism
    • S. cerevisiae
    • S. pombe
  • Thomas Gingeras
    Cold Spring Harbor Laboratory (USA)
    Research focus
    • Noncoding RNA
    • genome organisation
    • transcriptome analyses
    • DNA sequencing methods
    • computational biology
    Experimental Organism
    • Drosophila
    • Human
    • Mouse
  • Christopher Glass
    University of California, San Diego (USA)
    Research focus
    • Nuclear receptors
    • transcription
    • transcriptional genomics
    • macrophage biology
    • inflammation
    Experimental Organism
    • Human
    • Mouse
  • Michael R Green
    University of Massachusetts Medical School (USA)
    Research focus
    • Transcriptional regulation
    • RNA splicing
    • cancer molecular biology
    Experimental Organism
    • Human
    • Mouse
    • S. cerevisiae
  • Carol Greider
    Johns Hopkins University (USA)
    Research focus
    • Telomeres
    Experimental Organism
    • Mouse
    • S. cerevisiae
  • Roderic Guigó
    Center for Genomic Regulation (Spain)
    Research focus
    • Epigenetics
    • genome annotation
    • splicing
    • transcriptomics
    • computational biology
  • Elisa Izaurralde
    Max Planck Institute Development Biology (Germany)
    Research focus
    • RNA degradation
    • RNA–protein biochemistry
    • microRNAs
    Experimental Organism
    • Drosophila
    • Human
  • James T Kadonaga
    University of California, San Diego (USA)
    Research focus
    • Transcription
    • chromatin dynamics
    • chromosomal proteins
    Experimental Organism
    • Drosophila
    • Human
  • Philipp Khaitovich
    Partner Institute for Computational Biology (China)
    Research focus
    • Transcriptomics
    • comparative transcriptomics and metabolomics
    Experimental Organism
    • Human
    • Primates
  • Stephen C Kowalczykowski
    University of California, Davis (USA)
    Research focus
    • DNA–protein interactions
    • recombinational DNA repair
    • single-molecule biophysics
    Experimental Organism
    • E. coli
    • Human
    • S. cerevisiae
  • Todd C Mockler
    Donald Danforth Plant Science Center (USA)
    Research focus
    • Gene expression
    • transcriptome analyses
    • alternative splicing
    • RNA processing
    • circadian regulation
    • transcriptional regulation
    • plant genomics
    • transcriptomics
    • computational biology
    • gene networks
    • system biology
    • plant development
    • plant responses to the environment
    Experimental Organism
    • Arabidopsis
    • B. distachyon
  • Timothy Nilsen
    Case Western Reserve University (USA)
    Research focus
    • mRNA processing
    • mechanism of miRNA function
    • RNA–protein interactions
    • mRNP composition and function
    • RNA biology
    Experimental Organism
    • Drosophila
    • Human
    • Mouse
  • Roy Parker
    University of Colorado at Boulder (USA)
    Research focus
    • Protein synthesis
    • mRNA stability
  • Kathrin Plath
    University of California, Los Angeles (USA)
    Research focus
    • Reprogramming
    • X chromosome inactivation
    • embryonic stem cells
    • chromatin
    Experimental Organism
    • Mouse
  • Carol Prives
    Columbia University (USA)
    Research focus
    • Transcription
    • tumour suppressors
    • p53 in cell cycle
    • cell death
    • transcription and transformation
  • Nick J Proudfoot
    Oxford University (UK)
    Research focus
    • mRNA processing
    • transcription
    Experimental Organism
    • S. cerevisiae
    • S. pombe
    • Human
  • Danny Reinberg
    New York University (USA)
    Research focus
    • Epigenetics
    • chromatin biology
  • Bing Ren
    University of California, San Diego School of Medicine (USA)
    Research focus
    • Epigenetics
    • epigenomics
  • Ali Shilatifard
    Stowers Institute for Medical Research (USA)
    Research focus
    • Chromatin
    • ELLs
    • P-TEFb
    • Pol II
    • MLLs
    • chromosomal translocations and leukemia
    • enhancers
    • gene expression
    • transcription
    Experimental Organism
    • Drosophila
    • Human
    • Mouse
    • S. cerevisiae
  • Robert H Singer
    Albert Einstein College of Medicine (USA)
    Research focus
    • Transcription
    • mRNA localization
  • Nahum Sonenberg
    McGill University (Canada)
    Research focus
    • Protein synthesis
    • cell signalling and translation
    • translational control of memory
    Experimental Organism
    • Mouse
  • John Stamatoyannopoulos
    University of Washington (USA)
    Research focus
    • Epigenetics
    • chromatin structure
    • transcriptional regulation
  • Louis Staudt
    National Cancer Institute (USA)
    Research focus
    • Lymphocyte gene regulation
    • cancer genomics
    • lymphoid malignancies
    • lymphocyte signalling
    • gene regulation
  • Gisela Storz
    National Institute of Child Health and Human Development (USA)
    Research focus
    • Small noncoding RNAs
    • oxidative stress
    Experimental Organism
    • E. coli
  • Kevin Struhl
    Harvard Medical School (USA)
    Research focus
    • Chromatin biology
    • cancer biology
    • transcription
    • gene regulatory circuits
    • epigenetics
    • molecular biology
    Experimental Organism
    • Human cells
    • S. cerevisiae
  • Johannes Walter
    Harvard Medical School (USA)
    Research focus
    • Cell cycle
    • DNA replication
    • DNA repair
    Experimental Organism
    • Xenopus
  • Stephen C West
    London Research Institute (UK)
    Research focus
    • DNA recombination
    • DNA repair
  • Phil Zamore
    University of Massachusetts (USA)
    Research focus
    • RNA
    • RNA–protein biochemistry
    • enzymology
    • microRNAs
    Experimental Organism
    • Drosophila

Genomics & evolutionary biology

  • Julie Ahringer
    The Gurdon Institute (UK)
    Research focus
    • Cell fate
    • gene expression
    • chromatin biology
    • epigenetics
    Experimental Organism
    • C. elegans
  • Asifa Akhtar
    Max Planck Institute for Immunobiology and Epigenetics (Germany)
    Research focus
    • Gene expression
    • chromatin biology
    • epigenetics
    • transcription
    Experimental Organism
    • Drosophila
  • Richard Amasino
    University of Wisconsin (USA)
    Research focus
    • Epigenetics
    • plant development
    Experimental Organism
    • Arabidopsis
    • B. distachyon
  • Naama Barkai
    Weizmann Institute of Science (Israel)
    Research focus
    • Design principles of biological circuits
  • David Baulcombe
    Cambridge University (UK)
    Research focus
    • Epigenetics
    • RNA silencing
    • plant defence mechanisms
    Experimental Organism
    • Arabidopsis
  • Carl T Bergstrom
    University of Washington (USA)
    Research focus
    • Game theory
    • network science
    • evolution
  • Benjamin J Blencowe
    University of Toronto (Canada)
    Research focus
    • RNA processing
    • epigenomics
    • transcriptome analyses
    Experimental Organism
    • Human
    • Mouse
  • Jörg Bohlmann
    University of British Columbia (Canada)
    Research focus
    • Metabolism
    • chemical ecology
    • plant genomics
    Experimental Organism
    • Plants
  • Emmanouil T Dermitzakis
    University of Geneva (Switzerland)
    Research focus
    • Population genomics
    • complex traits
    • comparative genomics
    • genomic medicine
    Experimental Organism
    • Human
  • Marcel Dicke
    Wageningen University (The Netherlands)
    Research focus
    • Ecological entomology
    • plant–insect interactions
  • James Ferrell
    Stanford University (USA)
    Research focus
    • Cell cycle
    • systems biology
  • Nir Friedman
    The Hebrew University of Jerusalem (Israel)
    Research focus
    • Transcriptional regulation
    • comparative genomics
    • probabilistic models
    • computational biology
    Experimental Organism
    • S. cerevisiae
    • S. pombe
  • Thomas Gingeras
    Cold Spring Harbor Laboratory (USA)
    Research focus
    • Noncoding RNA
    • genome organisation
    • transcriptome analyses
    • DNA sequencing methods
    • computational biology
    Experimental Organism
    • Drosophila
    • Human
    • Mouse
  • Todd Golub
    Broad Institute of MIT and Harvard (USA)
    Research focus
    • Cancer genomics
    • haematology
    • genetics
    • drug discovery
    Experimental Organism
    • Human
  • Roderic Guigó
    Center for Genomic Regulation (Spain)
    Research focus
    • Epigenetics
    • genome annotation
    • splicing
    • transcriptomics
    • computational biology
  • Bin Han
    National Center for Gene Research (China)
    Research focus
    • Plant genomics
    • molecular breeding
    • plant genetics
    Experimental Organism
    • Rice
  • Maria J Harrison
    Boyce Thompson Institute for Plant Research (USA)
    Research focus
    • Plant–microbe symbioses
    • plant–microbe interactions
    • plant mineral nutrition
    Experimental Organism
    • Glomus
    • Medicago
  • Merijn R Kant
    University of Amsterdam (the Netherlands)
    Research focus
    • Chemical ecology
    • plant defense
    • plant–parasite interactions
    Experimental Organism
    • Tomato
    • insects
    • mites
  • Philipp Khaitovich
    Partner Institute for Computational Biology (China)
    Research focus
    • Transcriptomics
    • comparative transcriptomics and metabolomics
    Experimental Organism
    • Human
    • Primates
  • Daniel J Kliebenstein
    University of California, Davis (USA)
    Research focus
    • Plant–microbe interactions
    • quantitative genetics
    • genome-wide association studies
    • plant genomics
    • ecological genomics
    • fungal genomics
    • secondary metabolism
    • plant–insect interactions
  • Bruno Lemaître
    Ecole Polytechnique Fédérale de Lausanne (Switzerland)
    Research focus
    • Innate immunity
    • pattern recognition
    • entomopathogens
    Experimental Organism
    • D. melanogaster
  • Mark McCarthy
    Oxford University (UK)
    Research focus
    • Statistical genetics
    • genome-wide association studies
    • human genetics
    • diabetes
    Experimental Organism
    • Human
  • Gil McVean
    Oxford University (UK)
    Research focus
    • Population genetics
    • statistical genetics
    Experimental Organism
    • Human
  • Todd C Mockler
    Donald Danforth Plant Science Center (USA)
    Research focus
    • Gene expression
    • transcriptome analyses
    • alternative splicing
    • RNA processing
    • circadian regulation
    • transcriptional regulation
    • plant genomics
    • transcriptomics
    • computational biology
    • gene networks
    • system biology
    • plant development
    • plant responses to the environment
    Experimental Organism
    • Arabidopsis
    • B. distachyon
  • Sacha B Nelson
    Brandeis University (USA)
    Research focus
    • Genome-wide gene expression in the nervous system
    • cellular and systems neurophysiology
    • forebrain development and function
    • synaptic plasticity
    Experimental Organism
    • Mouse and other mammals
  • Mercedes Pascual
    University of Michigan (USA)
    Research focus
    • Population dynamics and pathogen diversity of infectious diseases
    • mathematical models in epidemiology
    • theoretical ecology
    • ecological networks
  • Molly Przeworski
    Columbia University (USA)
    Research focus
    • Population genetics
    • evolutionary biology
    • recombination
    Experimental Organism
    • Human
    • Primates
  • Wenying Shou
    Fred Hutchinson Cancer Research Center (USA)
    Research focus
    • Experimental evolution
    • evolution of cooperation
    • mathematical biology
  • John Stamatoyannopoulos
    University of Washington (USA)
    Research focus
    • Epigenetics
    • chromatin structure
    • transcriptional regulation
  • Louis Staudt
    National Cancer Institute (USA)
    Research focus
    • Lymphocyte gene regulation
    • cancer genomics
    • lymphoid malignancies
    • lymphocyte signalling
    • gene regulation
  • Kevin Struhl
    Harvard Medical School (USA)
    Research focus
    • Chromatin biology
    • cancer biology
    • transcription
    • gene regulatory circuits
    • epigenetics
    • molecular biology
    Experimental Organism
    • Human cells
    • S. cerevisiae
  • Sarah A Teichmann
    EMBL-European Bioinformatics Institute & Wellcome Trust Sanger Institute (UK)
    Research focus
    • Bioinformatics
    • genomics
    • transcriptomics
    • systems immunology
    • structural bioinformatics

Human biology & medicine

  • Utpal Banerjee
    University of California, Los Angeles (USA)
    Research focus
    • Haematopoiesis
    • cancer biology
    Experimental Organism
    • Drosophila
  • Michael S Brown
    UT Southwestern Medical Center (USA)
    Research focus
    • Membrane proteins
    • sterol metabolism
    Experimental Organism
    • Human
  • Pascale Cossart
    Institut Pasteur (France)
    Research focus
    • Host-bacterial pathogens interactions (cell biology
    • transcriptional regulation
    • post-transcriptional regulation)
    Experimental Organism
    • Listeria
  • Giulio Cossu
    University College London (UK)
    Research focus
    • Stem cells
    • cell therapy
    • muscular dystrophies
    • clinical trials of cell therapies
    Experimental Organism
    • Human
    • Mouse
  • Michael Czech
    University of Massachusetts Medical School (USA)
    Research focus
    • Insulin
    • metabolism
    • lipids
    • signal transduction
    • membranes
    • adipose
    • obesity
    • insulin resistance
    • diabetes
    Experimental Organism
    • Human
    • Mouse
  • Chi V Dang
    University of Pennsylvania (USA)
    Research focus
    • Cancer biology
  • Bart De Strooper
    VIB and KU Leuven (Belgium)
    Research focus
    • Protein processing
    • neurodegenerative diseases
    • animal models of human disease
    Experimental Organism
    • Human
    • Mouse
  • Emmanouil T Dermitzakis
    University of Geneva (Switzerland)
    Research focus
    • Population genomics
    • complex traits
    • comparative genomics
    • genomic medicine
    Experimental Organism
    • Human
  • Harry Dietz
    Johns Hopkins University (USA)
    Research focus
    • Human genetics
    • vascular biology and disease
    • mouse model of vascular disease
  • Joaquin Espinosa
    University of Colorado (USA)
    Research focus
    • Apoptosis
    • p53
    • tumor suppressors
    • cancer biology
  • Eduardo Franco
    McGill University (Canada)
    Research focus
    • Human biology and medicine
    • microbiology and infectious disease
    • cancer epidemiology and prevention
    • screening
    • human papillomavirus infection
    Experimental Organism
    • Human
  • Elaine Fuchs
    Rockefeller University (USA)
    Research focus
    • Skin stem cells
    • stem cells
    • tissue morphogenesis
    • epithelial polarity
    • transcriptional regulation during development
    • cytoskeletal dynamics and adhesion
    • epithelial cancers
    Experimental Organism
    • Mouse
  • David Ginsburg
    University of Michigan (USA)
    Research focus
    • Genetic diseases
    • mouse models of human disease
    • haematology
    Experimental Organism
    • Human
  • Todd Golub
    Broad Institute of MIT and Harvard (USA)
    Research focus
    • Cancer genomics
    • haematology
    • genetics
    • drug discovery
    Experimental Organism
    • Human
  • Michael R Green
    University of Massachusetts Medical School (USA)
    Research focus
    • Transcriptional regulation
    • RNA splicing
    • cancer molecular biology
    Experimental Organism
    • Human
    • Mouse
    • S. cerevisiae
  • Helen Hobbs
    UT Southwestern Medical Center (USA)
    Research focus
    • Lipid metabolism
    • cholesterol
    • human genetics
    • atherosclerosis
    Experimental Organism
    • Human
  • Eunjoon Kim
    Korea Advanced Institute of Science and Technology (South Korea)
    Research focus
    • Neurodevelopmental disorders
    • synapse formation
    • synaptic transmission
  • Pat Levitt
    University of Southern California (USA)
    Research focus
    • Neurodevelopmental disorders
    • brain development
    • neuropharmacology
    Experimental Organism
    • Human
  • Joan Massagué
    Memorial Sloan Kettering Cancer Center (USA)
    Research focus
    • Cell signaling
    • cell fate
    • tumor biology
    • metastasis
    Experimental Organism
    • Human tissue
    • Mouse
  • Mark McCarthy
    Oxford University (UK)
    Research focus
    • Statistical genetics
    • genome-wide association studies
    • human genetics
    • diabetes
    Experimental Organism
    • Human
  • Freda Miller
    The Hospital for Sick Children, University of Toronto (Canada)
    Research focus
    • Neural stem cells
    • neurodevelopmental disorders
    • neurotrophins
  • Hideyuki Okano
    Keio University (Japan)
    Research focus
    • Neural stem cells
    • inducted pluripotent stem cells
    • cell based therapies
    • spinal cord injury
    Experimental Organism
    • Mouse
    • Non-human primate (common marmoset)
  • Duojia Pan
    Johns Hopkins University (USA)
    Research focus
    • Signal transduction
    • growth control
    • cancer biology
    Experimental Organism
    • Drosophila
    • Mouse
  • Suzanne R Pfeffer
    Stanford University (USA)
    Research focus
    • Membrane traffic
    • golgi complex
    • endosomes
    • lysosomes
    • secretory pathway
    • endosomes
    • lysosomes
  • David M Sabatini
    Massachusetts Institute of Technology (USA)
    Research focus
    • Growth control
    • metabolism
    • caloric restriction
    • nutrient sensing
  • Sema Sgaier
    Bill & Melinda Gates Foundation (USA)
    Research focus
    • Human biology and medicine
    • disease control
    • epidemiology
  • Deepak Srivastava
    The Gladstone Institutes (USA)
    Research focus
    • Tissue stem cells
    • cardiac repair
    • cardiology
    Experimental Organism
    • Human
    • Mouse
  • Louis Staudt
    National Cancer Institute (USA)
    Research focus
    • Lymphocyte gene regulation
    • cancer genomics
    • lymphoid malignancies
    • lymphocyte signalling
    • gene regulation
  • Stephen Tollman
    Wits University (South Africa)
    Research focus
    • Human biology and medicine
    • mortality
    • disease control in low income countries
  • Peter Tontonoz
    University of California, Los Angeles (USA)
    Research focus
    • Nuclear receptors
    • lipid metabolism
    • obesity/diabetes
    • atherosclerosis
  • Gordana Vunjak-Novakovic
    Columbia University (USA)
    Research focus
    • In vitro models of development and disease
    • biophysical regulation of stem cells
    • cardiac and bone regeneration
    • tissue engineering
    Experimental Organism
    • Human
  • Gary L Westbrook
    Vollum Institute (USA)
    Research focus
    • Clinical neurology
    • synaptic transmission
    • olfactory system
    • hippocampus
  • Stephen G Young
    University of California, Los Angeles (USA)
    Research focus
    • Lipoproteins
    • nuclear lamins
    • atherosclerosis
    • triglyceride metabolism
    • cholesterol metabolism

Immunology

  • Xuetao Cao
    Zhejiang University School of Medicine (China)
    Research focus
    • Immunology of APCs
    • TLR signalling and immune regulation
    • cancer immunotherapy and gene therapy
  • Arup K Chakraborty
    Massachusetts Institute of Technology (USA)
    Research focus
    • Computational biology
    • immunology
    • statistical mechanics
    • signaling
    • virology
  • Ronald N Germain
    National Institute of Allergy and Infectious Diseases (USA)
    Research focus
    • T-cell receptor signalling
    • immune cell migration
    • cell–cell interaction
  • Christopher Glass
    University of California, San Diego (USA)
    Research focus
    • Nuclear receptors
    • transcription
    • transcriptional genomics
    • macrophage biology
    • inflammation
    Experimental Organism
    • Human
    • Mouse
  • Stephen P Goff
    Columbia University (USA)
    Research focus
    • Retrovirus replication
    • virus assembly
  • Beth Levine
    UT Southwestern Medical Center (USA)
    Research focus
    • Autophagy
    • innate immunity
    Experimental Organism
    • C. elegans
    • Mouse
  • Diane Mathis
    Harvard Medical School (USA)
    Research focus
    • T cell biology
    • immunoregulation
    • autoimmunity
  • Ruslan Medzhitov
    Yale University (USA)
    Research focus
    • Innate immunity
    • inflammation
    Experimental Organism
    • Mouse
  • Michel Nussenzweig
    Rockefeller University (USA)
    Research focus
    • Adaptive immunity
    • innate immunity
    • HIV
    • dendritic cells
    Experimental Organism
    • Mouse
  • Fiona M Powrie
    Oxford University (UK)
    Research focus
    • Mucosal immunity
    • inflammation
  • Satyajit Rath
    National Institute of Immunology (India)
    Research focus
    • Immune physiology
    • lymphocyte development
    • lymphocyte responses
    • macrophage activation
    • immunity in disease
  • Shimon Sakaguchi
    Osaka University (Japan)
    Research focus
    • Regulatory T cells
    • immune tolerance
    • autoimmune disease
    • tumor immunity
  • Feng Shao
    National Institute of Biological Sciences (China)
    Research focus
    • Bacterial infection
    • innate immunity
  • Louis Staudt
    National Cancer Institute (USA)
    Research focus
    • Lymphocyte gene regulation
    • cancer genomics
    • lymphoid malignancies
    • lymphocyte signalling
    • gene regulation

Microbiology & infectious disease

  • Axel Brakhage
    Leibniz Institute for Natural Product Research and Infection Biology – Hans Knöll Institute (Germany)
    Research focus
    • X-ray crystallography
    • single molecule microscopy
    • fungal pathogens
    • fungal secondary metabolism
    • biotechnology
    Experimental Organism
    • Aspergillus
  • Jon Clardy
    Harvard Medical School (USA)
    Research focus
    • Microbial secondary metabolism
    • chemical communications
    • biosynthesis
    • chemical biology
    • microbial chemical ecology
  • Pascale Cossart
    Institut Pasteur (France)
    Research focus
    • Host-bacterial pathogens interactions (cell biology
    • transcriptional regulation
    • post-transcriptional regulation)
    Experimental Organism
    • Listeria
  • Eduardo Franco
    McGill University (Canada)
    Research focus
    • Human biology and medicine
    • microbiology and infectious disease
    • cancer epidemiology and prevention
    • screening
    • human papillomavirus infection
    Experimental Organism
    • Human
  • Stephen P Goff
    Columbia University (USA)
    Research focus
    • Retrovirus replication
    • virus assembly
  • Peter Greenberg
    University of Washington (USA)
    Research focus
    • Microbe–microbe communication
  • Jean Greenberg
    University of Chicago (USA)
    Research focus
    • Local and long distance signalling in innate immunity
    • plant–microbe interactions
    • bacterial pathogens
    Experimental Organism
    • Arabidopsis
    • N. benthamiana
    • Tomato
    • Pseudomonas
  • Eduardo A Groisman
    Yale University (USA)
    Research focus
    • Bacterial pathogens
    • symbionts
  • Maria J Harrison
    Boyce Thompson Institute for Plant Research (USA)
    Research focus
    • Plant–microbe symbioses
    • plant–microbe interactions
    • plant mineral nutrition
    Experimental Organism
    • Glomus
    • Medicago
  • Simon I Hay
    Oxford University (UK)
    Research focus
    • Infectious diseases of the tropics
    • epidemiology
    Experimental Organism
    • Plasmodia
    • Leishmania
    • arboviruses
  • Mark Jit
    London School of Hygiene & Tropical Medicine, and Public Health England (UK)
    Research focus
    • Immunisation
    • health economics
    • mathematical modelling of infectious diseases
  • Daniel J Kliebenstein
    University of California, Davis (USA)
    Research focus
    • Plant–microbe interactions
    • quantitative genetics
    • genome-wide association studies
    • plant genomics
    • ecological genomics
    • fungal genomics
    • secondary metabolism
    • plant–insect interactions
  • Roberto Kolter
    Harvard Medical School (USA)
    Research focus
    • Microbe–microbe interactions
    • plant–microbe interactions
    Experimental Organism
    • Model bacteria including Bacillus subtilis
    • Streptomyces coelicolor
    • Staphylococcus aureus
  • Michael Laub
    Massachusetts Institute of Technology (USA)
    Research focus
    • Bacterial cell cycle
    • bacterial systems biology
    • signal transduction
  • Wenhui Li
    National Institute of Biological Sciences, Beijing (China)
    Research focus
    • Viral entry
    • hepatitis B virus
    • hepatitis D virus
  • Thorsten Nürnberger
    University of Tübingen (Germany)
    Research focus
    • Innate immunity
    • plant–microbe interactions
    • plant immunity
    Experimental Organism
    • Arabidopsis
  • Michel Nussenzweig
    Rockefeller University (USA)
    Research focus
    • Adaptive immunity
    • innate immunity
    • HIV
    • dendritic cells
    Experimental Organism
    • Mouse
  • Mercedes Pascual
    University of Michigan (USA)
    Research focus
    • Population dynamics and pathogen diversity of infectious diseases
    • mathematical models in epidemiology
    • theoretical ecology
    • ecological networks
  • Feng Shao
    National Institute of Biological Sciences (China)
    Research focus
    • Bacterial infection
    • innate immunity
  • Gisela Storz
    National Institute of Child Health and Human Development (USA)
    Research focus
    • Small noncoding RNAs
    • oxidative stress
    Experimental Organism
    • E. coli
  • Wesley Sundquist
    University of Utah (USA)
    Research focus
    • Virus-host interactions
    • retroviruses
    • HIV
    Experimental Organism
    • Human cells
  • Nicholas J White
    Mahidol University (Thailand)
    Research focus
    • malaria
    • drug discovery and therapeutics
    Experimental Organism
    • P. falciparum
    • P. vivax
    • B. pseudomallei

Neuroscience

  • Richard Aldrich
    The University of Texas at Austin (USA)
    Research focus
    • Ion channels
    • conformational changes
    • calcium signaling
    • calmodulin
    • kinetics
  • Marlene Bartos
    University of Freiburg (Germany)
    Research focus
    • Synaptic transmission
    • GABAergic cells
    • network oscillations
    • synaptic plasticity
  • Timothy Behrens
    Oxford University (UK)
    Research focus
    • Brain imaging
    • fMRI
    • learning
    Experimental Organism
    • Human
    • Macaque monkeys
  • Andrea Brand
    The Gurdon Institute (UK)
    Research focus
    • Neural stem cells
    • neural development
    • developmental neurobiology
    Experimental Organism
    • Drosophila
  • Marianne E Bronner
    California Institute of Technology (USA)
    Research focus
    • Neural crest
    • peripheral nervous system
    • placodes
    • developmental neurobiology
    Experimental Organism
    • Chick
    • Lamprey
    • Zebrafish
    • Xenopus
  • Axel T Brunger
    Stanford University (USA)
    Research focus
    • Synaptic transmission
    • neurotransmitters
  • Ronald L Calabrese
    Emory University (USA)
    Research focus
    • Motor pattern generation
    • neuronal and small networks models
    • electrophysiological properties of neurons and synapse
    • computational neuroscience
    Experimental Organism
    • Leech
  • Matteo Carandini
    University College London (UK)
    Research focus
    • Cerebral cortex
    • neurons
    • visual system
    Experimental Organism
    • Mouse
  • Jonathan A Cooper
    Fred Hutchinson Cancer Research Center (USA)
    Research focus
    • Signal transduction
    • neuronal migration
    Experimental Organism
    • Mouse
  • Jody C Culham
    Western University (Canada)
    Research focus
    • Brain imaging
    • fMRI
    • cognitive neuroscience
    • vision
    Experimental Organism
    • Human
  • Graeme Davis
    University of California, San Francisco (USA)
    Research focus
    • Neurodegeneration
    • neural development
    • synaptic transmission
    • plasticity
    Experimental Organism
    • Drosophila
  • Bart De Strooper
    VIB and KU Leuven (Belgium)
    Research focus
    • Protein processing
    • neurodegenerative diseases
    • animal models of human disease
    Experimental Organism
    • Human
    • Mouse
  • Howard Eichenbaum
    Boston University (USA)
    Research focus
    • Cognitive neurobiology
    • hippocampus
    • memory
    Experimental Organism
    • Rat
  • Russ Fernald
    Stanford University (USA)
    Research focus
    • Behavioral biology
    • epigenetics
    • genomics
    Experimental Organism
    • Cichlids
  • Leslie C Griffith
    Brandeis University (USA)
    Research focus
    • Behavioral biology
    • molecular neurobiology
    • electrophysiology
    Experimental Organism
    • Drosophila
  • Michael Häusser
    University College London (UK)
    Research focus
    • Neurophysiology
    • synaptic integration
    • neural computation
  • Oliver Hobert
    Columbia University (USA)
    Research focus
    • MicroRNAs
    • epigenetics
    • developmental neurobiology
    Experimental Organism
    • C. elegans
  • Reinhard Jahn
    Max Planck Institute for Biophysical Chemistry (Germany)
    Research focus
    • Membrane proteins
    • secretion
    • synaptic transmission
  • Nancy Kanwisher
    Massachusetts Institute of Technology (USA)
    Research focus
    • fMRI
    • human cognitive neuroscience
    • visual cognition
    Experimental Organism
    • Human
  • Ole Kiehn
    Karolinska Institute (Sweden)
    Research focus
    • Neural circuits
    • motor
    • spinal cord
    Experimental Organism
    • Mouse
  • Eunjoon Kim
    Korea Advanced Institute of Science and Technology (South Korea)
    Research focus
    • Neurodevelopmental disorders
    • synapse formation
    • synaptic transmission
  • Robb Krumlauf
    Stowers Institute for Medical Research (USA)
    Research focus
    • Hox genes
    • vertebrate development
    • axial patterning
    • craniofacial development
    • gene regulatory networks
    • developmental neurobiology
    Experimental Organism
    • Mouse
  • Pat Levitt
    University of Southern California (USA)
    Research focus
    • Neurodevelopmental disorders
    • brain development
    • neuropharmacology
    Experimental Organism
    • Human
  • Liqun Luo
    Stanford University (USA)
    Research focus
    • Developmental neurobiology
    • neural circuits
    • olfaction
    Experimental Organism
    • Drosophila
    • Mouse
  • Peggy Mason
    University of Chicago (USA)
    Research focus
    • Nociceptive modulation
    • pain
    • serotonin
    • empathy
    • bulbospinal modulation
  • Freda Miller
    The Hospital for Sick Children, University of Toronto (Canada)
    Research focus
    • Neural stem cells
    • neurodevelopmental disorders
    • neurotrophins
  • Jeremy Nathans
    Johns Hopkins University (USA)
    Research focus
    • Developmental neurobiology
    • planar cell polarity
    • photoreceptors
    • vision
    • ophthalmology
    Experimental Organism
    • Mouse
  • Sacha B Nelson
    Brandeis University (USA)
    Research focus
    • Genome-wide gene expression in the nervous system
    • cellular and systems neurophysiology
    • forebrain development and function
    • synaptic plasticity
    Experimental Organism
    • Mouse and other mammals
  • Richard Palmiter
    University of Washington (USA)
    Research focus
    • Genetics and behaviour
    • body weight control
    • catecholamines
    • mitochondria
    Experimental Organism
    • Mouse
  • Franck Polleux
    Columbia University (USA)
    Research focus
    • Cortical development
    • neuronal polarity
    • neuronal migration
    • axon and dendrite development
    • brain evolution
    Experimental Organism
    • Human
    • Mouse
  • Louis Ptáĉek
    University of California, San Francisco (USA)
    Research focus
    • Neurogenetics
    • circadian rhythms/sleep
    • episodic disorders
    Experimental Organism
    • Human
    • Mouse
  • Mani Ramaswami
    Trinity College, Dublin (Ireland)
    Research focus
    • Neurogenetics
    • neural circuits
    • olfaction
    • learning and memory
    • mechanisms of neuronal translational control
    • mRNA localization
    • synaptic plasticity
    Experimental Organism
    • Drosophila
  • Ranulfo Romo
    Universidad Nacional Autónoma de México (Mexico)
    Research focus
    • Sensory encoding
    • perception
    • decision-making
    • working memory
    • brain circuits
  • Christian Rosenmund
    Charité (Germany)
    Research focus
    • Synaptic transmission
    • neurotransmitter release
    • exocytosis
    • plasticity
    Experimental Organism
    • Mouse and other mammals
  • Frances K Skinner
    Toronto Western Research Institute, University Health Network (Canada)
    Research focus
    • Computational neuroscience
    • mathematical modeling
    • neurological diseases
  • Nahum Sonenberg
    McGill University (Canada)
    Research focus
    • Protein synthesis
    • cell signalling and translation
    • translational control of memory
    Experimental Organism
    • Mouse
  • Gary L Westbrook
    Vollum Institute (USA)
    Research focus
    • Clinical neurology
    • synaptic transmission
    • olfactory system
    • hippocampus

Plant biology

  • Richard Amasino
    University of Wisconsin (USA)
    Research focus
    • Epigenetics
    • plant development
    Experimental Organism
    • Arabidopsis
    • B. distachyon
  • David Baulcombe
    Cambridge University (UK)
    Research focus
    • Epigenetics
    • RNA silencing
    • plant defence mechanisms
    Experimental Organism
    • Arabidopsis
  • Dominique Bergmann
    Stanford University (USA)
    Research focus
    • Cell polarity
    • plant development
    Experimental Organism
    • Arabidopsis
  • Jörg Bohlmann
    University of British Columbia (Canada)
    Research focus
    • Metabolism
    • chemical ecology
    • plant genomics
    Experimental Organism
    • Plants
  • Joanne Chory
    Salk Institute for Biological Studies (USA)
    Research focus
    • Hormone biosynthesis and metabolism
    • signal transduction
    • plant development
    Experimental Organism
    • Arabidopsis
  • Marcel Dicke
    Wageningen University (The Netherlands)
    Research focus
    • Ecological entomology
    • plant–insect interactions
  • Jean Greenberg
    University of Chicago (USA)
    Research focus
    • Local and long distance signalling in innate immunity
    • plant–microbe interactions
    • bacterial pathogens
    Experimental Organism
    • Arabidopsis
    • N. benthamiana
    • Tomato
    • Pseudomonas
  • Bin Han
    National Center for Gene Research (China)
    Research focus
    • Plant genomics
    • molecular breeding
    • plant genetics
    Experimental Organism
    • Rice
  • Christian S Hardtke
    University of Lausanne (Switzerland)
    Research focus
    • Computational model of development
    • plant development
    Experimental Organism
    • Arabidopsis
  • Maria J Harrison
    Boyce Thompson Institute for Plant Research (USA)
    Research focus
    • Plant–microbe symbioses
    • plant–microbe interactions
    • plant mineral nutrition
    Experimental Organism
    • Glomus
    • Medicago
  • Daniel J Kliebenstein
    University of California, Davis (USA)
    Research focus
    • Plant–microbe interactions
    • quantitative genetics
    • genome-wide association studies
    • plant genomics
    • ecological genomics
    • fungal genomics
    • secondary metabolism
    • plant–insect interactions
  • Roberto Kolter
    Harvard Medical School (USA)
    Research focus
    • Microbe–microbe interactions
    • plant–microbe interactions
    Experimental Organism
    • Model bacteria including Bacillus subtilis
    • Streptomyces coelicolor
    • Staphylococcus aureus
  • Sheila McCormick
    University of California, Berkeley & USDA Agricultural Research Service (USA)
    Research focus
    • Cell polarity
    • signal transduction
    • plant gametophyte development
    • reproductive biology
    Experimental Organism
    • Arabidopsis
    • Tomato
  • Todd C Mockler
    Donald Danforth Plant Science Center (USA)
    Research focus
    • Gene expression
    • transcriptome analyses
    • alternative splicing
    • RNA processing
    • circadian regulation
    • transcriptional regulation
    • plant genomics
    • transcriptomics
    • computational biology
    • gene networks
    • system biology
    • plant development
    • plant responses to the environment
    Experimental Organism
    • Arabidopsis
    • B. distachyon
  • Thorsten Nürnberger
    University of Tübingen (Germany)
    Research focus
    • Innate immunity
    • plant–microbe interactions
    • plant immunity
    Experimental Organism
    • Arabidopsis

Board of Directors

  • Toby Coppel

    Toby Coppel is a Partner of Virgin Management, an international investment group and one of the world's most recognised and respected brands. He is responsible for managing Virgin's portfolio of companies and for new investments. He is a member of the board of directors of Virgin Galactic, Virgin Care, Virgin Mobile France and Virgin Pure. Toby is also responsible for Virgin's investments in technology start-ups including Twitter, Square, Path and Hailo. Toby has a strong track record of principal investing in growth companies and extensive operational experience. Prior to joining Virgin, Toby held a number of senior executive roles at Yahoo!, including Chief Strategy Officer, and Managing Director, Yahoo! Europe. Prior to Yahoo!, Toby was a co-founder of Windsor Media, an investment firm he started with former Yahoo! CEO Terry Semel and LinkedIn CEO Jeff Weiner. Toby also held investment and advisory roles with Allen & Company and Goldman Sachs. Toby is a Henry Crown Fellow at The Aspen Institute and a member of the advisory board at the Oxford Internet Institute. Toby is a graduate of Oxford University and Harvard Business School.

  • Christian Hernandez Gallardo

    Christian Hernandez Gallardo has over 16 years of operating experience in technology companies, developing and scaling products and businesses internationally. Prior to co-founding White Star Capital, Christian worked at Facebook and led the international expansion of the company's Business Development, Platform and Gaming Partnerships groups. He previously held leadership roles in the US and Europe at Google and Microsoft and started his career in technology at MicroStrategy, a start-up he joined prior to its 1999 IPO. Christian has worked closely with entrepreneurs and leading VCs and has been an active angel investor and advisor. He serves on the Board of Advisors of Seedcamp and the Digital Task force for the EVCA. Christian holds a degree in Economics from Duke University and an MBA from The Wharton School. Born in El Salvador and having grown up across the Latin America, the US and Europe, he now resides in London with his wife and three children.

  • Bill S Hansson

    Bill S Hansson is vice president of the Max Planck Society and Director at the Max Planck institute for chemical ecology. He was born in Jonstorp, in the south of Sweden, and studied biology at the University of Lund. After his PhD in ecology and a postdoctoral stay in the United States, he became Professor for Chemical Ecology, first in Lund and, beginning in 2001, at the Swedish University of Agricultural Sciences (SLU) in Alnarp. In 2006, he was appointed Director at the Max Planck Institute for Chemical Ecology in Jena, Germany, and Scientific Member of the Max Planck Society. As vice president of the Max Planck Society, Bill Hansson's main area of responsibility is the biological-medical section, where he is in charge of science and functionality in general. He also has a general responsibility for internationality and construction within the Max Planck Society. As head of the Department of Evolutionary Neuroethology, Bill Hansson focuses on neurophysiological and behavioral aspects of interactions between insects and their host plants. His main research interest is insect olfaction: How do insects detect odors, how is semiochemical information processed in the insect brain, and how does olfaction affect insect behavior? Bill Hansson is Honorary Professor at Friedrich Schiller University in Jena and a fellow of several national and international science academies, such as the Royal Swedish Academy of Sciences and the Royal Entomological Society. He has also received several distinguished awards for his research. He has lived in Jena with his wife and two children since 2007. Nevertheless, he maintains close ties to his home country, where he and his family usually spend the summer in their own forest.

  • Kevin Moses

    Kevin Moses is Director of Science Funding at the Wellcome Trust, a global charitable foundation dedicated to achieving extraordinary improvements in health by supporting the brightest minds. Before he joined the Trust in July 2011, Kevin was the founding Chief Academic Officer at the Howard Hughes Medical Institute's Janelia Farm Research Campus. Previously, he held faculty positions at Emory University and the University of Southern California, where he led a research group that studied morphogenetic mechanisms in the development of the Drosophila compound eye. Image ©Wellcome Library, London

  • Robert Tjian

    Robert Tjian has been president of the Howard Hughes Medical Institute since April 2009. Trained as a biochemist, he has made major contributions to the understanding of how genes work during three decades on the faculty of the University of California, Berkeley. He was named an HHMI investigator in 1987. Tjian studies the biochemical steps involved in controlling how genes are turned on and off, key steps in the process of decoding the human genome. He discovered proteins called transcription factors that bind to specific sections of DNA and play a critical role in controlling how genetic information is transcribed and translated into the thousands of biomolecules that keep cells, tissues, and organisms alive. Tjian's laboratory has illuminated the relationship between disruptions in the process of transcription and human diseases such as cancer, diabetes, and Huntington's. More recently, he has begun studying how transcription factors control the differentiation of embryonic stem cells into muscle, liver, and neurons. Tjian received a bachelor's degree in biochemistry from Berkeley in 1971 and a Ph.D. from Harvard University in 1976. After completing a postdoctoral fellowship at the Cold Spring Harbor Laboratory with James Watson, he joined the Berkeley faculty in 1979. At Berkeley, Tjian assumed a variety of leadership roles, including spearheading a major campus initiative to support and implement new paradigms for bioscience teaching and research. He served as the Director of the Berkeley Stem Cell Center, and the Faculty Director of the Li Ka Shing Center for Biomedical and Health Sciences. He is a member of the National Academy of Sciences and has received many awards honoring his scientific contributions, including the Alfred P. Sloan Prize from the General Motors Cancer Research Foundation and the Louisa Gross Horwitz Prize from Columbia University. He was named California Scientist of the Year in 1994. Tjian remains an active scientist. His small laboratory group at HHMI's Janelia Farm Research Campus focuses on the development of new approaches to image biochemical activities in single living cells. He also maintains a research laboratory at UC Berkeley, where he is a professor of biochemistry and molecular biology.

  • Mark Walport

    Sir Mark is the Chief Scientific Adviser to HM Government and Head of the Government Office for Science. Previously, Sir Mark was Director of the Wellcome Trust, which is a global charitable foundation dedicated to achieving extraordinary improvements in human and animal health by supporting the brightest minds. Before joining the Trust he was Professor of Medicine and Head of the Division of Medicine at Imperial College London. He has been a member of the Prime Minister's Council for Science and Technology since 2004. He has also been a member of the India UK CEO Forum, the UK India Round Table and the advisory board of Infrastructure UK and a non-executive member of the Office for Strategic Coordination of Health Research. He is a member of a number of international advisory bodies. He has undertaken independent reviews for the UK Government on the use and sharing of personal information in the public and private sectors: 'Data Sharing Review' (2009); and secondary education: 'Science and Mathematics: Secondary Education for the 21st Century' (2010). He received a knighthood in the 2009 New Year Honours List for services to medical research and was elected as Fellow of The Royal Society in 2011. Image ©Wellcome Library, London

Executive Staff

  • Andy Collings

    After seven enjoyable years at PLOS, most latterly as Editorial manager for PLOS Computational Biology and PLOS Genetics, Andy joined eLife as the Managing editor in April 2012. Reporting to the Executive director, Andy has overall responsibility for the day-to-day running and editorial health of the journal, so if you have any feedback or ideas, please contact him: a.collings [at] elifesciences.org.

  • Lena Dowdall

    l.dowdall[at]elifesciences[dot]org

  • Laura Fullerton-Batten

    l.fullerton-batten [at] elifesciences [dot] org

  • James Gilbert

    James Gilbert joined eLife in May 2012, having previously worked as a production assistant at BioMed Central. He has a degree in Natural Sciences and a Masters in History of Science from Durham University. He works with both the Editorial and Production teams to ensure the smooth review and publication of articles at eLife.

    j.gilbert[at]elifesciences[dot]org

  • Melissa Harrison

    Melissa Harrison joins eLife as head of production operations and is instrumental in setting up the systems required to peer review and publish the content as efficiently as possible, utilizing new technologies and pushing available systems and vendors to the next level in automatable publication. She comes with good knowledge of production systems and technical requirements, and aims to advocate best practice in structuring and tagging content for reuse and mining, which is a crucial component of open-access publishing. Melissa spent a large part of her career at the BMJ Group working on the specialist journals, starting as production editor and working her way up to operations manager when she left. Since graduating from Kings College London with a degree in Biological Sciences she pursued her career in publishing and has fulfilled a number of roles in small publishing houses, from desk top publishing and cover design to commissioning and writing. She is also a fully trained copy editor. Melissa spent a short time working for an Indian publishing services vendor and so has experience of both sides of the fence. m.harrison [at] elifesciences [dot] org

  • Ruth Ivimey-Cook

    Ruth joined the development team at eLife in October 2013 to work on Journal website development and systems. Most recently working as a freelance Drupal developer, Ruth has had a long career in many aspects of software development, including databases, websites, technical documentation, inkjet printing and systems development. From 2007 to 2010 she was the product manager for Global Graphics' page renderer output packages, helping to quantify its value to the business and improve the product offering, while also developing skills in colour science and profiling.

    She has also been a member on the committee of WoTUG, a Computer Science conference organiser, and has an enduring interest in science and the exploration of the natural world. Having seen the bad effects of the inappropriate use of journal Impact Factor, Ruth is excited by the journey eLife is on and is very keen to see it succeed.

    blog: www.ivimey.org

    r.ivimeycook[at]elifesciences[dot]org

    LinkedIn: www.linkedin.com/in/ruthivimeycook_

    Twitter: rivimey

  • Paul Kelly

    p.kelly [at] elifesciences [dot] org

  • Stuart King

    Stuart joined eLife in November 2013 following a PhD in molecular plant pathology at the John Innes Centre and the Sainsbury Laboratory in Norwich, UK. Before that, he completed an undergraduate degree in biological sciences at Oxford.

    s.king [at] elifesciences [dot] org

  • Nathan Lisgo

    n.lisgo [at] elifesciences [dot] org

  • Jennifer McLennan

    Jennifer comes to eLife with nearly seven years advocating for change in research communication and scholarly publishing with SPARC (the Scholarly Publishing and Academic Resources Coalition), which represents over 800 academic and research institutions worldwide and is a leading supporter of open access. As director of programs, Jennifer was responsible for the successful realization and promotion of SPARC initiatives – from grassroots legislative activism to organization mobilization on a global scale. Prior to SPARC, Jennifer led marketing and public relations for academic publishers and nonprofit organizations. She holds a Bachelor of Arts from the University of Victoria and a Master's degree in Business Administration from Athabasca University – both in Canada. Ç_ j.mclennan [at] elifesciences [dot] org.

  • Jenny Mitchell

    j.mitchell [at] elifesciences [dot] org   Twitter - @ScienceScoops

  • David Moulton

    d.moulton [at] elifesciences [dot] org

  • Ian Mulvany

    Ian started out with a background in astrophysics, and in 2002 he joined Springer, where he managed the copy editing of physical sciences content. He went on to work as a publishing editor for a number of Springer journals and book series in areas ranging form materials science to biophysics and the philosophy of science. A growing sense of discontent with the services that publishers were creating for readers and authors led him to Nature where he worked on developing online tools for researchers. While at Nature he was instrumental in the relaunch of Nature Network. In 2010 he took up the role of VP Product for Mendeley. From 2010–2012, Mendeley grew to over 1.5 million users, with more than 180 million documents uploaded to the service. Ian was responsible for major product launches, leading the product vision and implimenting a lightweight, but functional delivery process. He is passionate about the potential for web technologies to transform research communication and is deeply dissastisfied with the limits that our current tools impose upon us. Ç_ blog:Ç_http://partiallyattended.com/ i.mulvany [at] elifesciences [dot] org

  • Mark Patterson

    Mark Patterson was a researcher in human and yeast genetics for 12 years before moving into scientific publishing in 1994 as the Editor of Trends in Genetics. After a few years at Nature, where he was involved in the launch of the Nature Reviews Journals, he moved to the non-profit open-access startup publisher PLoS in 2003. As an editor, Mark helped to launch several of the PLoS Journals and was appointed as Director of Publishing in 2005. He was also one of the founders of the Open Access Scholarly Publishers Association. In November 2011, Mark joined the eLife team and has been building the professional staff team in Cambridge, UK, to help get the journal off the ground. m.patterson [at] elifesciences [dot] org

  • Emma Pewsey

    Emma joined eLife in January 2014 whilst writing up her PhD about the corrosion of orthopaedic implants. Before this, she did a degree in natural sciences at the University of Cambridge, specialising in materials science. Her move from the lab into publishing was motivated by winning the Access to Understanding science-writing competition in 2013, for which one of the prizes was publication of her article in eLife.

    e.pewsey [at] elifesciences [dot] org

  • Siân Roderick

    Siân joins eLife, one of the world's newest scientific publishing companies, from one of the oldest, the Royal Society. She comes with the knowledge of more than 10 years in production at a range of publishers and has hands-on experience of all areas of the production process. Having graduated from Aberdeen University with a degree in physiology, Siân joined Future Drugs as a production editor where she was involved in all aspects of the production process. She then moved to the British Institute of Radiology's publishing team as production editor and later production coordinator working on both journals and books, before making her way through the ranks at the Royal Society from senior production editor to production manager. s.roderick [at] elifesciences [dot] org

  • Peter Rodgers

    Peter joined eLife as Features Editor in June 2012 and has worked in scientific publishing for more than twenty years. As Features Editor he oversees the non-research content of eLife and also the textbook summaries that will be included in all research papers. Previously he has been the Chief Editor of Nature Nanotechnology (2006-2012), where he had overall responsibility for all research and non-research content, and the Editor of Physics World magazine (1996-2005). Peter has a degree in physics from Imperial College London (1984) and a PhD from the Queen's University of Belfast (1988), and worked at the Rutherford Appleton Laboratory before joining Physics World as an Assistant Editor in 1990.

  • Frances Rogers

    f.rogers[at]elifesciences[dot]org

  • Joe Salter

    j.salter [at] elifesciences [dot] org

  • Alina Sudra

    a.sudra [at] elifesciences [dot] org

Review process

At eLife, we’ve taken a fresh approach to peer review to save you time, and to provide clear direction and constructive input. Decisions are quick and efficient; revision requests are designed to be clear and manageable; and multiple rounds of revision are usually avoided. Here's how it works:

  1. Initial decisions are delivered quickly

    Our Senior editors decide whether initial submissions are appropriate for in-depth peer review, usually in consultation with members of the Board of Reviewing Editors.
  2. Active scientists make all decisions

    A Senior editor assigns a member of the Board of Reviewing Editors to oversee the peer-review process. The Reviewing editor usually reviews the article him or herself, calling on one or two additional reviewers as needed.
  3. Revision requests are consolidated

    Reviewers get together online to discuss their recommendations, refining their feedback, and striving to provide clear and concise guidance. If the work needs essential revisions before it can be published, the Reviewing editor incorporates those requirements into a single set of instructions.
  4. Limited rounds of revision

    Additional rounds of revision are largely eliminated, as the Reviewing editor is able to assess most revised submissions without further outside review.
  5. Decisions and responses are available for all to read

    In the interests of openness and transparency we publish the most substantive parts of the decision letter after review and the associated author responses, subject to author agreement.
3
days to initial decision *
29
days to post-review decision *
90
days submission to acceptance *
* median times, through the end of April 2014

Working on something interesting?

Let us know now